Idx,Title,node-A,edge,node-B,Context
395,NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m6A methylation through upregulation of METTL3 transcription,NRF1,INHIBITS,motor dysfunction,mice with Parkinson's disease
395,NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m6A methylation through upregulation of METTL3 transcription,NRF1,INHIBITS,dopamine neuron degeneration,mice with Parkinson's disease
395,NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m6A methylation through upregulation of METTL3 transcription,NRF1,STIMULATES,METTL3 transcription,mice with Parkinson's disease
395,NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m6A methylation through upregulation of METTL3 transcription,METTL3 transcription,STIMULATES,GLRX m6A methylation,mice with Parkinson's disease
395,NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m6A methylation through upregulation of METTL3 transcription,GLRX m6A methylation,INHIBITS,motor dysfunction,mice with Parkinson's disease
395,NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m6A methylation through upregulation of METTL3 transcription,GLRX m6A methylation,INHIBITS,dopamine neuron degeneration,mice with Parkinson's disease
396,ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control,ALKBH5,AFFECTS,energy metabolism,hematopoietic stem and progenitor cell
396,ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control,ALKBH5,AFFECTS,m6A,hematopoietic stem and progenitor cell
396,ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control,m6A,AFFECTS,RNA stability control,hematopoietic stem and progenitor cell
396,ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control,RNA stability control,AFFECTS,energy metabolism,hematopoietic stem and progenitor cell
386,IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner,IGF2BP3,STIMULATES,progression,colorectal cancer
386,IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner,IGF2BP3,AFFECTS,cetuximab resistance,colorectal cancer
386,IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner,IGF2BP3,AFFECTS,m6A,colorectal cancer
386,IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner,m6A,MAINTAINS,EGFR,colorectal cancer
386,IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner,EGFR,MAINTAINS,progression,colorectal cancer
386,IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner,EGFR,MAINTAINS,cetuximab resistance,colorectal cancer
397,YTHDF2 facilitates aggresome formation via UPF1 in an m6A-independent manner,YTHDF2,STIMULATES,aggresome formation,Null
397,YTHDF2 facilitates aggresome formation via UPF1 in an m6A-independent manner,YTHDF2,INTERACTS_WITH,m6A,Null
397,YTHDF2 facilitates aggresome formation via UPF1 in an m6A-independent manner,m6A,AFFECTS,UPF1,Null
397,YTHDF2 facilitates aggresome formation via UPF1 in an m6A-independent manner,UPF1,STIMULATES,aggresome formation,Null
387,RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA.,IGF2BP3,STIMULATES,progression,acute myeloid leukemia
387,RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA.,IGF2BP3,MAINTAINS,EPOR mRNA,acute myeloid leukemia
387,RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA.,EPOR mRNA,STIMULATES,progression,acute myeloid leukemia
398,The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression.,YTHDC1,INTERACTS_WITH,m6A,cholangiocarcinoma
398,The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression.,CTBP1-AS2,AFFECTS,m6A,cholangiocarcinoma
398,The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression.,m6A,STIMULATES,progression,cholangiocarcinoma
399,YTHDF2 promotes DNA damage repair by positively regulating the histone methyltransferase SETDB1 in spermatogonia.,YTHDF2,STIMULATES,DNA damage repair,spermatogonia
399,YTHDF2 promotes DNA damage repair by positively regulating the histone methyltransferase SETDB1 in spermatogonia.,YTHDF2,STIMULATES,SETDB1,spermatogonia
399,YTHDF2 promotes DNA damage repair by positively regulating the histone methyltransferase SETDB1 in spermatogonia.,SETDB1,STIMULATES,DNA damage repair,spermatogonia
388,The m6A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy,KIAA1429,MAINTAINS,RAB27B,chronic myeloid leukemia
388,The m6A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy,KIAA1429,STIMULATES,progression,chronic myeloid leukemia
388,The m6A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy,KIAA1429,PREVENTS,targeted therapy,chronic myeloid leukemia
389,N6-methyladenosine-induced METTL1 promotes tumor proliferation via CDK4.,N6-methyladenosine,CAUSES,METTL1,Null
389,N6-methyladenosine-induced METTL1 promotes tumor proliferation via CDK4.,METTL1,STIMULATES,tumor proliferation,Null
389,N6-methyladenosine-induced METTL1 promotes tumor proliferation via CDK4.,METTL1,AFFECTS,CDK4,Null
389,N6-methyladenosine-induced METTL1 promotes tumor proliferation via CDK4.,CDK4,STIMULATES,tumor proliferation,Null
390,YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation,YTHDF2,STIMULATES,progression,gallbladder cancer
390,YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation,YTHDF2,STIMULATES,gemcitabine resistance,gallbladder cancer
390,YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation,YTHDF2,INTERACTS_WITH,m6A,gallbladder cancer
390,YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation,m6A,AFFECTS,DAPK3 degradation,gallbladder cancer
390,YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation,DAPK3 degradation,STIMULATES,progression,gallbladder cancer
390,YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation,DAPK3 degradation,STIMULATES,gemcitabine resistance,gallbladder cancer
391,METTL3 exacerbates insulin resistance in hepatocytes by regulating m6A modification of cytochrome P450 2B6,METTL3,COMPLICATES,insulin resistance,hepatocytes
391,METTL3 exacerbates insulin resistance in hepatocytes by regulating m6A modification of cytochrome P450 2B6,METTL3,AFFECTS,m6A,hepatocytes
391,METTL3 exacerbates insulin resistance in hepatocytes by regulating m6A modification of cytochrome P450 2B6,m6A,LOCATES,cytochrome P450 2B6,hepatocytes
391,METTL3 exacerbates insulin resistance in hepatocytes by regulating m6A modification of cytochrome P450 2B6,cytochrome P450 2B6,COMPLICATES,insulin resistance,hepatocytes
392,VIRMA promotes neuron apoptosis via inducing m6A methylation of STK10 in spinal cord injury animal models.,VIRMA,STIMULATES,neuron apoptosis,spinal cord injury animal models
392,VIRMA promotes neuron apoptosis via inducing m6A methylation of STK10 in spinal cord injury animal models.,VIRMA,CAUSES,m6A,spinal cord injury animal models
392,VIRMA promotes neuron apoptosis via inducing m6A methylation of STK10 in spinal cord injury animal models.,m6A,LOCATES,STK10,spinal cord injury animal models
392,VIRMA promotes neuron apoptosis via inducing m6A methylation of STK10 in spinal cord injury animal models.,STK10,STIMULATES,neuron apoptosis,spinal cord injury animal models
393,METTL3 Regulates the m6A Modification of NEK7 to Inhibit the Formation of Osteoarthritis,METTL3,AFFECTS,m6A,Osteoarthritis
393,METTL3 Regulates the m6A Modification of NEK7 to Inhibit the Formation of Osteoarthritis,m6A,LOCATES,NEK7,Osteoarthritis
393,METTL3 Regulates the m6A Modification of NEK7 to Inhibit the Formation of Osteoarthritis,NEK7,INHIBITS,formation,Osteoarthritis
394,M6A-mediated upregulation of HOXC10 promotes human hepatocellular carcinoma development through PTEN/AKT/mTOR signaling pathway,M6A,STIMULATES,HOXC10,human hepatocellular carcinoma
394,M6A-mediated upregulation of HOXC10 promotes human hepatocellular carcinoma development through PTEN/AKT/mTOR signaling pathway,HOXC10,STIMULATES,development,human hepatocellular carcinoma
394,M6A-mediated upregulation of HOXC10 promotes human hepatocellular carcinoma development through PTEN/AKT/mTOR signaling pathway,HOXC10,AFFECTS,PTEN/AKT/mTOR signaling pathway,human hepatocellular carcinoma
394,M6A-mediated upregulation of HOXC10 promotes human hepatocellular carcinoma development through PTEN/AKT/mTOR signaling pathway,PTEN/AKT/mTOR signaling pathway,STIMULATES,development,human hepatocellular carcinoma
368,"ALKBH5-mediated RNA m6A methylation regulates the migration, invasion and proliferation of rheumatoid fibroblast-like synoviocytes.",ALKBH5,AFFECTS,m6A,rheumatoid fibroblast-like synoviocytes
368,"ALKBH5-mediated RNA m6A methylation regulates the migration, invasion and proliferation of rheumatoid fibroblast-like synoviocytes.",m6A,AFFECTS,migration,rheumatoid fibroblast-like synoviocytes
368,"ALKBH5-mediated RNA m6A methylation regulates the migration, invasion and proliferation of rheumatoid fibroblast-like synoviocytes.",m6A,AFFECTS,invasion,rheumatoid fibroblast-like synoviocytes
368,"ALKBH5-mediated RNA m6A methylation regulates the migration, invasion and proliferation of rheumatoid fibroblast-like synoviocytes.",m6A,AFFECTS,proliferation,rheumatoid fibroblast-like synoviocytes
369,RNA m6A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression.,YTHDF2,STIMULATES,miR-126,acute myeloid leukemia
369,RNA m6A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression.,miR-126,STIMULATES,progression,acute myeloid leukemia
370,Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells.,Alkbh5,MAINTAINS,self-renewal,hematopoietic stem cells
371,A cleaved METTL3 potentiates the METTL3-WTAP interaction and breast cancer progression.,METTL3,STIMULATES,METTL3-WTAP interaction,breast cancer
371,A cleaved METTL3 potentiates the METTL3-WTAP interaction and breast cancer progression.,METTL3,STIMULATES,progression,breast cancer
372,Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-dependent Manner.,Gemcitabine,INHIBITS,Progression,Pancreatic Cancer
372,Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-dependent Manner.,Gemcitabine,AFFECTS,m6A,Pancreatic Cancer
372,Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-dependent Manner.,m6A,INHIBITS,WTAP/MYC Chain,Pancreatic Cancer
372,Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-dependent Manner.,WTAP/MYC Chain,INHIBITS,Progression,Pancreatic Cancer
373,METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression,METTL14,STIMULATES,growth,non-small cell lung cancer
373,METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression,METTL14,STIMULATES,metastasis,non-small cell lung cancer
373,METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression,METTL14,AFFECTS,pri-miR-93-5p,non-small cell lung cancer
373,METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression,METTL14,AFFECTS,TXNIP,non-small cell lung cancer
373,METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression,pri-miR-93-5p,STIMULATES,growth,non-small cell lung cancer
373,METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression,pri-miR-93-5p,STIMULATES,metastasis,non-small cell lung cancer
373,METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression,TXNIP,STIMULATES,growth,non-small cell lung cancer
373,METTL14 drives growth and metastasis of non-small cell lung cancer by regulating pri-miR-93-5p maturation and TXNIP expression,TXNIP,STIMULATES,metastasis,non-small cell lung cancer
374,Xanthine derivatives inhibit FTO in an L-ascorbic acid-dependent manner.,Xanthine derivatives,INHIBITS,FTO,Null
374,Xanthine derivatives inhibit FTO in an L-ascorbic acid-dependent manner.,Xanthine derivatives,AFFECTS,L-ascorbic acid,Null
374,Xanthine derivatives inhibit FTO in an L-ascorbic acid-dependent manner.,L-ascorbic acid,INHIBITS,FTO,Null
375,RNA N6-methyladenosine methyltransferase WTAP promotes the differentiation of endothelial progenitor cells,WTAP,STIMULATES,differentiation,endothelial progenitor cells
376,"Kar4, the yeast homolog of METTL14, is required for mRNA m6A methylation and meiosis",Kar4,CAUSES,m6A,Null
376,"Kar4, the yeast homolog of METTL14, is required for mRNA m6A methylation and meiosis",Kar4,CAUSES,meiosis,Null
377,miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.,miR-33a-3p,AFFECTS,METTL3,pancreatic cancer
377,miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.,METTL3,AFFECTS,AREG,pancreatic cancer
377,miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.,miR-33a-3p,AFFECTS,EMT,pancreatic cancer
377,miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.,AREG,INHIBITS,invasion,pancreatic cancer
377,miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.,AREG,INHIBITS,metastasis,pancreatic cancer
377,miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.,EMT,INHIBITS,invasion,pancreatic cancer
377,miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.,EMT,INHIBITS,metastasis,pancreatic cancer
379,METTL3-modified lncRNA-MALAT1 regulates the molecular axis of miR-124-3p/CDK4 involved in Ewing's sarcoma,METTL3,AFFECTS,lncRNA-MALAT1,Ewing's sarcoma
379,METTL3-modified lncRNA-MALAT1 regulates the molecular axis of miR-124-3p/CDK4 involved in Ewing's sarcoma,lncRNA-MALAT1,AFFECTS,miR-124-3p/CDK4,Ewing's sarcoma
380,METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis.,METTL3,STIMULATES,growth,Melanoma Cells
380,METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis.,METTL3,STIMULATES,invasion,Melanoma Cells
380,METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis.,METTL3,AFFECTS,lncRNA SNHG3/miR-330-5p Axis,Melanoma Cells
380,METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis.,lncRNA SNHG3/miR-330-5p Axis,STIMULATES,growth,Melanoma Cells
380,METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis.,lncRNA SNHG3/miR-330-5p Axis,STIMULATES,invasion,Melanoma Cells
381,eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation.,eIF3i,STIMULATES,survival,colorectal cancer cell
381,eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation.,eIF3i,AUGMENTS,PHGDH,colorectal cancer cell
381,eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation.,PHGDH,STIMULATES,survival,colorectal cancer cell
382,ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner.,ALKBH5,STIMULATES,apoptosis,hypopharyngeal squamous cell carcinoma
382,ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner.,ALKBH5,AFFECTS,YTHDF1,hypopharyngeal squamous cell carcinoma
382,ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner.,ALKBH5,AFFECTS,IGF2BP2,hypopharyngeal squamous cell carcinoma
382,ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner.,YTHDF1,INTERACTS_WITH,TLR2,hypopharyngeal squamous cell carcinoma
382,ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner.,IGF2BP2,INTERACTS_WITH,TLR2,hypopharyngeal squamous cell carcinoma
382,ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner.,TLR2,STIMULATES,apoptosis,hypopharyngeal squamous cell carcinoma
383,M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.,M6A,STIMULATES,lncRNA BLACAT3,bladder cancer
383,M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.,lncRNA BLACAT3,STIMULATES,angiogenesis,bladder cancer
383,M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.,lncRNA BLACAT3,STIMULATES,hematogenous metastasis,bladder cancer
383,M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.,lncRNA BLACAT3,AFFECTS,YBX3,bladder cancer
383,M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.,lncRNA BLACAT3,AUGMENTS,NCF2 transcription,bladder cancer
383,M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.,YBX3,STIMULATES,angiogenesis,bladder cancer
383,M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.,YBX3,STIMULATES,hematogenous metastasis,bladder cancer
383,M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.,NCF2 transcription,STIMULATES,angiogenesis,bladder cancer
383,M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.,NCF2 transcription,STIMULATES,hematogenous metastasis,bladder cancer
302,METTL3-mediated m6A modification of Bcl-2 mRNA promotes non-small cell lung cancer progression.,METTL3,AFFECTS,m6A,non-small cell lung cancer
302,METTL3-mediated m6A modification of Bcl-2 mRNA promotes non-small cell lung cancer progression.,m6A,LOCATES,Bcl-2,non-small cell lung cancer
302,METTL3-mediated m6A modification of Bcl-2 mRNA promotes non-small cell lung cancer progression.,Bcl-2,STIMULATES,progression,non-small cell lung cancer
243,METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma.,METTL3,AFFECTS,m6A,lung adenocarcinoma
243,METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma.,m6A,LOCATES,FBXW7,lung adenocarcinoma
243,METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma.,FBXW7,INHIBITS,lung adenocarcinoma,lung adenocarcinoma
145,ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner.,ALKBH5,STIMULATES,proliferation,renal cell carcinoma
145,ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner.,ALKBH5,AFFECTS,m6A,renal cell carcinoma
145,ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner.,m6A,AFFECTS,AURKB,renal cell carcinoma
145,ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner.,AURKB,STIMULATES,proliferation,renal cell carcinoma
195,YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.,YTHDF1,STIMULATES,progression,hepatocellular carcinoma
195,YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.,YTHDF1,INTERACTS_WITH,m6A,hepatocellular carcinoma
195,YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.,m6A,STIMULATES,FZD5,hepatocellular carcinoma
195,YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.,FZD5,STIMULATES,progression,hepatocellular carcinoma
47,N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1alpha signalling axis.,FTO,INHIBITS,clear cell renal cell carcinoma,clear cell renal cell carcinoma
47,N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1alpha signalling axis.,FTO,AFFECTS,FTO-PGC-1alpha signalling axis,clear cell renal cell carcinoma
47,N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1alpha signalling axis.,FTO-PGC-1alpha signalling axis,INHIBITS,clear cell renal cell carcinoma,clear cell renal cell carcinoma
238,FTO modifies the m6A level of MALAT and promotes bladder cancer progression.,FTO,AFFECTS,m6A,bladder cancer
238,FTO modifies the m6A level of MALAT and promotes bladder cancer progression.,m6A,LOCATES,MALAT,bladder cancer
238,FTO modifies the m6A level of MALAT and promotes bladder cancer progression.,FTO,STIMULATES,progression,bladder cancer
48,The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-kappaB/MYC signaling network.,METTL3,STIMULATES,progression,bladder cancer
48,The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-kappaB/MYC signaling network.,METTL3,AFFECTS,AFF4/NF-kappaB/MYC signaling network,bladder cancer
48,The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-kappaB/MYC signaling network.,AFF4/NF-kappaB/MYC signaling network,STIMULATES,progression,bladder cancer
112,FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation.,FTO,STIMULATES,cell progression,lung adenocarcinoma
112,FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation.,FTO,AFFECTS,mRNA demethylation,lung adenocarcinoma
112,FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation.,mRNA demethylation,STIMULATES,cell migration,lung adenocarcinoma
112,FTO Facilitates Lung Adenocarcinoma Cell Progression by Activating Cell Migration Through mRNA Demethylation.,cell migration,STIMULATES,cell progression,lung adenocarcinoma
284,RNA m6A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/beta-catenin signaling.,YTHDF2,STIMULATES,cell proliferation,lung adenocarcinoma
284,RNA m6A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/beta-catenin signaling.,YTHDF2,STIMULATES,metastasis,lung adenocarcinoma
284,RNA m6A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/beta-catenin signaling.,YTHDF2,INTERACTS_WITH,AXIN1/Wnt/beta-catenin signaling,lung adenocarcinoma
284,RNA m6A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/beta-catenin signaling.,AXIN1/Wnt/beta-catenin signaling,STIMULATES,cell proliferation,lung adenocarcinoma
284,RNA m6A reader YTHDF2 facilitates lung adenocarcinoma cell proliferation and metastasis by targeting the AXIN1/Wnt/beta-catenin signaling.,AXIN1/Wnt/beta-catenin signaling,STIMULATES,metastasis,lung adenocarcinoma
158,ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1.,ALKBH5,INHIBITS,malignancy,hepatocellular carcinoma
158,ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1.,ALKBH5,AFFECTS,m6A,hepatocellular carcinoma
158,ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1.,m6A,INHIBITS,LYPD1,hepatocellular carcinoma
158,ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1.,LYPD1,INHIBITS,malignancy,hepatocellular carcinoma
93,YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.,dummy,INHIBITS,YTHDF2,hepatocellular carcinoma
93,YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.,YTHDF2,STIMULATES,inflammation,hepatocellular carcinoma
93,YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.,YTHDF2,STIMULATES,vascular abnormalization,hepatocellular carcinoma
87,m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation.,FTO,STIMULATES,tumorigenesis,hepatocellular carcinoma
87,m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation.,FTO,CONVERTS_TO,PKM2,hepatocellular carcinoma
87,m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation.,PKM2,STIMULATES,tumorigenesis,hepatocellular carcinoma
350,METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of alpha-klotho.,METTL14,STIMULATES,glomerular endothelial cell injury,diabetic nephropathy
350,METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of alpha-klotho.,METTL14,STIMULATES,diabetic nephropathy,diabetic nephropathy
350,METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of alpha-klotho.,METTL14,AFFECTS,m6A,diabetic nephropathy
350,METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of alpha-klotho.,m6A,LOCATES,alpha-klotho,diabetic nephropathy
350,METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of alpha-klotho.,alpha-klotho,STIMULATES,glomerular endothelial cell injury,diabetic nephropathy
350,METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of alpha-klotho.,alpha-klotho,STIMULATES,diabetic nephropathy,diabetic nephropathy
307,ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.,ALKBH5,CONVERTS_TO,m6A,T-cell acute lymphoblastic leukemia cell
307,ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.,m6A,LOCATES,USP1,T-cell acute lymphoblastic leukemia cell
307,ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.,USP1,AFFECTS,glucocorticoid resistance,T-cell acute lymphoblastic leukemia cell
307,ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.,USP1,AFFECTS,Aurora B,T-cell acute lymphoblastic leukemia cell
307,ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.,Aurora B,AFFECTS,glucocorticoid resistance,T-cell acute lymphoblastic leukemia cell
356,METTL3 induces PLX4032 resistance in melanoma by promoting m6A-dependent EGFR translation.,METTL3,PREVENTS,PLX4032,melanoma
356,METTL3 induces PLX4032 resistance in melanoma by promoting m6A-dependent EGFR translation.,METTL3,STIMULATES,m6A,melanoma
356,METTL3 induces PLX4032 resistance in melanoma by promoting m6A-dependent EGFR translation.,m6A,AFFECTS,EGRF,melanoma
356,METTL3 induces PLX4032 resistance in melanoma by promoting m6A-dependent EGFR translation.,EGRF,PREVENTS,PLX4032,melanoma
149,METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.,METTL14,AFFECTS,M6A,cardiovascular endothelial cell
149,METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.,M6A,AFFECTS,miR-19a,cardiovascular endothelial cell
149,METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.,miR-19a,STIMULATES,proliferation,cardiovascular endothelial cell
149,METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.,miR-19a,STIMULATES,invasion,cardiovascular endothelial cell
293,YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.,YTHDF1,STIMULATES,progression,hepatocellular carcinoma
293,YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.,YTHDF1,STIMULATES,PI3K/AKT/mTOR signaling pathway,hepatocellular carcinoma
293,YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.,YTHDF1,CAUSES,epithelial-mesenchymal transition.,hepatocellular carcinoma
293,YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.,PI3K/AKT/mTOR signaling pathway,STIMULATES,progression,hepatocellular carcinoma
293,YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.,epithelial-mesenchymal transition.,STIMULATES,progression,hepatocellular carcinoma
78,The RNA demethylase FTO is required for maintenance of bone mass and functions to protect osteoblasts from genotoxic damage.,FTO,MAINTAINS,bone mass,osteoblasts
78,The RNA demethylase FTO is required for maintenance of bone mass and functions to protect osteoblasts from genotoxic damage.,FTO,PREVENTS,genotoxic damage,osteoblasts
378,m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway.,FTO,INHIBITS,gemcitabine resistance,pancreatic cancer
378,m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway.,FTO,AFFECTS,PTEN/PI3K/AKT pathway,pancreatic cancer
378,m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway.,PTEN/PI3K/AKT pathway,AFFECTS,NEDD4,pancreatic cancer
378,m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway.,NEDD4,INHIBITS,gemcitabine resistance,pancreatic cancer
225,YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway.,YTHDF2,INHIBITS,cell growth,Gastric Cancer
225,YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway.,YTHDF2,AFFECTS,FOXC2 signaling pathway,Gastric Cancer
225,YTHDF2 Inhibits Gastric Cancer Cell Growth by Regulating FOXC2 Signaling Pathway.,FOXC2 signaling pathway,INHIBITS,cell growth,Gastric Cancer
203,METTL14 Overexpression Promotes Osteosarcoma Cell Apoptosis and Slows Tumor Progression via Caspase 3 Activation.,METTL14,STIMULATES,Apoptosis,Osteosarcoma
203,METTL14 Overexpression Promotes Osteosarcoma Cell Apoptosis and Slows Tumor Progression via Caspase 3 Activation.,METTL14,INHIBITS,Tumor Progression,Osteosarcoma
203,METTL14 Overexpression Promotes Osteosarcoma Cell Apoptosis and Slows Tumor Progression via Caspase 3 Activation.,METTL14,STIMULATES,Caspase 3,Osteosarcoma
203,METTL14 Overexpression Promotes Osteosarcoma Cell Apoptosis and Slows Tumor Progression via Caspase 3 Activation.,Caspase 3,STIMULATES,Apoptosis,Osteosarcoma
203,METTL14 Overexpression Promotes Osteosarcoma Cell Apoptosis and Slows Tumor Progression via Caspase 3 Activation.,Caspase 3,INHIBITS,Tumor Progression,Osteosarcoma
323,Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway.,dummy,INHIBITS,YTHDC2,Malignant Lung Cells
323,Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway.,YTHDC2,STIMULATES,Proliferation,Malignant Lung Cells
323,Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway.,YTHDC2,STIMULATES,Migration,Malignant Lung Cells
323,Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway.,YTHDC2,AFFECTS,CYLD/NF-kappaB Pathway,Malignant Lung Cells
323,Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway.,CYLD/NF-kappaB Pathway,STIMULATES,Proliferation,Malignant Lung Cells
323,Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-kappaB Pathway.,CYLD/NF-kappaB Pathway,STIMULATES,Migration,Malignant Lung Cells
340,m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer.,METTL14,STIMULATES,Cytidine Deaminase,Pancreatic Cancer
340,m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer.,Cytidine Deaminase,STIMULATES,Gemcitabine Resistance,Pancreatic Cancer
355,VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification.,VIRMA,AFFECTS,Progression,Non-small cell lung cancer
355,VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification.,VIRMA,AFFECTS,N6-methyladenosine,Non-small cell lung cancer
355,VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification.,N6-methyladenosine,LOCATES,DAPK3,Non-small cell lung cancer
355,VIRMA contributes to non-small cell lung cancer progression via N6-methyladenosine-dependent DAPK3 post-transcriptional modification.,DAPK3,AFFECTS,Progression,Non-small cell lung cancer
151,HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.,HDAC3,AFFECTS,FOXA2,Gastric Cancer
151,HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.,FOXA2,AFFECTS,FTO/m6A/MYC signaling,Gastric Cancer
151,HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.,FTO/m6A/MYC signaling,AFFECTS,Development,Gastric Cancer
174,METTL3 contributes to renal ischemia-reperfusion injury by regulating Foxd1 methylation.,METTL3,AFFECTS,Renal Ischemia-Reperfusion Injury,Renal Ischemia-Reperfusion Injury
174,METTL3 contributes to renal ischemia-reperfusion injury by regulating Foxd1 methylation.,METTL3,CONVERTS_TO,Foxd1,Renal Ischemia-Reperfusion Injury
174,METTL3 contributes to renal ischemia-reperfusion injury by regulating Foxd1 methylation.,Foxd1,AFFECTS,Renal Ischemia-Reperfusion Injury,Renal Ischemia-Reperfusion Injury
161,METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.,METTL14,COMPLICATES,Endothelial inflammation,Atherosclerosis
161,METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.,METTL14,COMPLICATES,Atherosclerosis,Atherosclerosis
161,METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.,METTL14,AUGMENTS,N6-methyladeosine,Atherosclerosis
161,METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.,N6-methyladeosine,LOCATES,FOXO1,Atherosclerosis
161,METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.,FOXO1,COMPLICATES,Endothelial inflammation,Atherosclerosis
161,METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.,FOXO1,COMPLICATES,Atherosclerosis,Atherosclerosis
171,Enterotoxigenic Escherichia coli infection promotes enteric defensin expression via FOXO6-METTL3-m6A-GPR161 signaling axis.,Enterotoxigenic Escherichia coli infection,STIMULATES,enteric defensin expression,Enterotoxigenic Escherichia coli infection
171,Enterotoxigenic Escherichia coli infection promotes enteric defensin expression via FOXO6-METTL3-m6A-GPR161 signaling axis.,Enterotoxigenic Escherichia coli infection,AFFECTS,FOXO6-METTL3-m6A-GPR161 signaling axis,Enterotoxigenic Escherichia coli infection
171,Enterotoxigenic Escherichia coli infection promotes enteric defensin expression via FOXO6-METTL3-m6A-GPR161 signaling axis.,FOXO6-METTL3-m6A-GPR161 signaling axis,STIMULATES,enteric defensin expression,Enterotoxigenic Escherichia coli infection
156,NADP modulates RNA m6A methylation and adipogenesis via enhancing FTO activity.,NADP,AUGMENTS,FTO,Null
156,NADP modulates RNA m6A methylation and adipogenesis via enhancing FTO activity.,FTO,AFFECTS,m6A methylation,Null
156,NADP modulates RNA m6A methylation and adipogenesis via enhancing FTO activity.,FTO,AFFECTS,adipogenesis,Null
156,NADP modulates RNA m6A methylation and adipogenesis via enhancing FTO activity.,NADP,AFFECTS,m6A methylation,Null
156,NADP modulates RNA m6A methylation and adipogenesis via enhancing FTO activity.,NADP,AFFECTS,adipogenesis,Null
264,Autophagy of the m6A mRNA demethylase FTO is impaired by low-level arsenic exposure to promote tumorigenesis.,Low-level arsenic exposure,DISRUPTS,FTO,Null
264,Autophagy of the m6A mRNA demethylase FTO is impaired by low-level arsenic exposure to promote tumorigenesis.,FTO,STIMULATES,Tumorigenesis,Null
227,Triclosan-induced abnormal expression of miR-30b regulates fto-mediated m6A methylation level to cause lipid metabolism disorder in zebrafish.,Triclosan,DISRUPTS,miR-30b,zebrafish
227,Triclosan-induced abnormal expression of miR-30b regulates fto-mediated m6A methylation level to cause lipid metabolism disorder in zebrafish.,miR-30b,AFFECTS,FTO,zebrafish
227,Triclosan-induced abnormal expression of miR-30b regulates fto-mediated m6A methylation level to cause lipid metabolism disorder in zebrafish.,FTO,AFFECTS,m6A,zebrafish
227,Triclosan-induced abnormal expression of miR-30b regulates fto-mediated m6A methylation level to cause lipid metabolism disorder in zebrafish.,m6A,CAUSES,lipid metabolism disorder,zebrafish
29,Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m6A-YTHDF2-dependent manner.,Epigallocatechin gallate,INTERACTS_WITH,FTO,Null
29,Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m6A-YTHDF2-dependent manner.,Epigallocatechin gallate,INHIBITS,adipogenesis,Null
29,Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m6A-YTHDF2-dependent manner.,Epigallocatechin gallate,AFFECTS,m6A,Null
29,Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m6A-YTHDF2-dependent manner.,YTHDF2,INTERACTS_WITH,m6A,Null
29,Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m6A-YTHDF2-dependent manner.,m6A,INHIBITS,adipogenesis,Null
254,AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation.,AMD1,STIMULATES,Stemness,Hepatocellular Carcinoma
254,AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation.,AMD1,AFFECTS,FTO,Hepatocellular Carcinoma
254,AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation.,FTO,AFFECTS,mRNA demethylation,Hepatocellular Carcinoma
254,AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation.,mRNA demethylation,STIMULATES,Stemness,Hepatocellular Carcinoma
198,Hsa-let-7b-5p Inhibits Proliferation of Human Leukemia THP-1 Cells via FTO/m6A/MYC Signaling Pathway.,Hsa-let-7b-5p,INHIBITS,Proliferation,Human Leukemia THP-1 Cells
198,Hsa-let-7b-5p Inhibits Proliferation of Human Leukemia THP-1 Cells via FTO/m6A/MYC Signaling Pathway.,Hsa-let-7b-5p,AFFECTS,FTO/m6A/MYC Signaling Pathway,Human Leukemia THP-1 Cells
198,Hsa-let-7b-5p Inhibits Proliferation of Human Leukemia THP-1 Cells via FTO/m6A/MYC Signaling Pathway.,FTO/m6A/MYC Signaling Pathway,INHIBITS,Proliferation,Human Leukemia THP-1 Cells
236,Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism.,YTHDF1,SENSITIZES,Cisplatin-resistant colon cancer cells,Cisplatin-resistant colon cancer
236,Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism.,YTHDF1,AFFECTS,GLS,Cisplatin-resistant colon cancer
236,Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism.,GLS,AFFECTS,glutamine metabolism,Cisplatin-resistant colon cancer
236,Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism.,glutamine metabolism,CAUSES,Cisplatin-resistant colon cancer,Cisplatin-resistant colon cancer
296,METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression.,METTL3,STIMULATES,Metastasis,Esophageal Squamous Cell Carcinoma
296,METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression.,METTL3,AUGMENTS,GLS2,Esophageal Squamous Cell Carcinoma
296,METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression.,GLS2,STIMULATES,Metastasis,Esophageal Squamous Cell Carcinoma
83,METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance.,METTL3,AFFECTS,m6A,Gastric Cancer
83,METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance.,m6A,LOCATES,HDGF,Gastric Cancer
83,METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance.,HDGF,STIMULATES,Progression,Gastric Cancer
209,N6-methyladenosine (m6A) methyltransferase WTAP accelerates the Warburg effect of gastric cancer through regulating HK2 stability.,WTAP,STIMULATES,Warburg effect,Gastric Cancer
209,N6-methyladenosine (m6A) methyltransferase WTAP accelerates the Warburg effect of gastric cancer through regulating HK2 stability.,WTAP,AFFECTS,HK2,Gastric Cancer
209,N6-methyladenosine (m6A) methyltransferase WTAP accelerates the Warburg effect of gastric cancer through regulating HK2 stability.,HK2,STIMULATES,Warburg effect,Gastric Cancer
127,METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.,METTL14,STIMULATES,Migration,Breast Cancer
127,METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.,METTL14,STIMULATES,Invasion,Breast Cancer
127,METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.,METTL14,AFFECTS,N6-methyladenosine,Breast Cancer
127,METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.,METTL14,AFFECTS,hsa-miR-146a-5p,Breast Cancer
127,METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.,N6-methyladenosine,STIMULATES,Migration,Breast Cancer
127,METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.,hsa-miR-146a-5p,STIMULATES,Migration,Breast Cancer
127,METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.,N6-methyladenosine,STIMULATES,Invasion,Breast Cancer
127,METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression.,hsa-miR-146a-5p,STIMULATES,Invasion,Breast Cancer
258,HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.,HNRNPA2B1,STIMULATES,Progression,Multiple Myeloma
258,HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.,HNRNPA2B1,INTERACTS_WITH,m6A,Multiple Myeloma
258,HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.,m6A,MAINTAINS,ILF3,Multiple Myeloma
258,HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.,ILF3,AUGMENTS,AKT3,Multiple Myeloma
258,HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.,AKT3 expression,STIMULATES,Progression,Multiple Myeloma
287,ALKBH5-modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease Via Innate Immune Response.,ALKBH5,AFFECTS,HMGB1-STING Activation,Radiation Induced Liver Disease
287,ALKBH5-modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease Via Innate Immune Response.,HMGB1-STING Activation,AFFECTS,Radiation Induced Liver Disease,Radiation Induced Liver Disease
287,ALKBH5-modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease Via Innate Immune Response.,HMGB1-STING Activation,AFFECTS,Innate Immune Response,Radiation Induced Liver Disease
287,ALKBH5-modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease Via Innate Immune Response.,Innate Immune Response,AFFECTS,Radiation Induced Liver Disease,Radiation Induced Liver Disease
360,METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d.,METTL3,AFFECTS,m6A,Prostate Cancer
360,METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d.,m6A,LOCATES,KIF3C-mRNA,Prostate Cancer
360,METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d.,miR-320d,INHIBITS,KIF3C-mRNA,Prostate Cancer
360,METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d.,KIF3C-mRNA,STIMULATES,Progression,Prostate Cancer
129,m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.,METTL3,STIMULATES,Progression,Prostate Cancer
129,m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.,METTL3,AFFECTS,m6A,Prostate Cancer
129,m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.,m6A,LOCATES,LEF1,Prostate Cancer
129,m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.,LEF1,STIMULATES,Progression,Prostate Cancer
114,GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m6A on lipogenic mRNAs.,GR,AFFECTS,FTO transactivation,Hepatocytes
114,GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m6A on lipogenic mRNAs.,FTO transactivation,CAUSES,Lipid Accumulation,Hepatocytes
114,GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m6A on lipogenic mRNAs.,FTO transactivation,CONVERTS_TO,m6A,Hepatocytes
114,GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m6A on lipogenic mRNAs.,m6A,LOCATES,lipogenic mRNAs,Hepatocytes
114,GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m6A on lipogenic mRNAs.,lipogenic mRNAs,AFFECTS,Lipid Accumulation,Hepatocytes
250,METTL3 Regulates Ossification of the Posterior Longitudinal Ligament via the lncRNA XIST/miR-302a-3p/USP8 Axis.,METTL3,AFFECTS,Ossification,Ossification of the Posterior Longitudinal Ligament
250,METTL3 Regulates Ossification of the Posterior Longitudinal Ligament via the lncRNA XIST/miR-302a-3p/USP8 Axis.,METTL3,AFFECTS,lncRNA XIST/miR-302a-3p/USP8 Axis,Ossification of the Posterior Longitudinal Ligament
250,METTL3 Regulates Ossification of the Posterior Longitudinal Ligament via the lncRNA XIST/miR-302a-3p/USP8 Axis.,lncRNA XIST/miR-302a-3p/USP8 Axis,AFFECTS,Ossification,Ossification of the Posterior Longitudinal Ligament
36,ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation.,ALKBH5,INHIBITS,Motility,Pancreatic Cancer
36,ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation.,ALKBH5,INHIBITS,KCNK15-AS1,Pancreatic Cancer
36,ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation.,KCNK15-AS1,INHIBITS,Motility,Pancreatic Cancer
157,Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation.,dummy,INHIBITS,METTL3,Triple-Negative Breast Cancer
157,Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation.,METTL3,STIMULATES,Metastasis,Triple-Negative Breast Cancer
157,Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation.,METTL3,AFFECTS,m6A,Triple-Negative Breast Cancer
157,Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation.,m6A,STIMULATES,COL3A1,Triple-Negative Breast Cancer
157,Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation.,COL3A1,STIMULATES,Metastasis,Triple-Negative Breast Cancer
210,METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner.,METTL14,INHIBITS,Metastasis,Hepatocellular Carcinoma
210,METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner.,METTL14,AFFECTS,m6A,Hepatocellular Carcinoma
210,METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner.,m6A,AFFECTS,EGFR/PI3K/AKT Signaling Pathway,Hepatocellular Carcinoma
210,METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner.,EGFR/PI3K/AKT Signaling Pathway,INHIBITS,Metastasis,Hepatocellular Carcinoma
327,METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner.,METTL3,STIMULATES,Temozolomide,Glioma
327,METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner.,METTL3,AFFECTS,m6A,Glioma
327,METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner.,m6A,AUGMENTS,MGMT,Glioma
327,METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner.,m6A,AUGMENTS,ANPG,Glioma
327,METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner.,MGMT,STIMULATES,Resistance to Temozolomide,Glioma
327,METTL3 Promotes the Resistance of Glioma to Temozolomide via Increasing MGMT and ANPG in a m6A Dependent Manner.,ANPG,STIMULATES,Resistance to Temozolomide,Glioma
336,ALKBH5 promotes cadmium-induced transformation of human bronchial epithelial cells by regulating PTEN expression in an m6A-dependent manner.,ALKBH5,STIMULATES,cadmium-induced transformation,human bronchial epithelial cell
336,ALKBH5 promotes cadmium-induced transformation of human bronchial epithelial cells by regulating PTEN expression in an m6A-dependent manner.,ALKBH5,AFFECTS,m6A,human bronchial epithelial cell
336,ALKBH5 promotes cadmium-induced transformation of human bronchial epithelial cells by regulating PTEN expression in an m6A-dependent manner.,m6A,AFFECTS,PTEN,human bronchial epithelial cell
336,ALKBH5 promotes cadmium-induced transformation of human bronchial epithelial cells by regulating PTEN expression in an m6A-dependent manner.,PTEN,STIMULATES,cadmium-induced transformation,human bronchial epithelial cell
116,METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification.,METTL3,STIMULATES,Tumorigenesis,Oral Squamous Cell Carcinoma
116,METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification.,METTL3,AFFECTS,YTHDF1,Oral Squamous Cell Carcinoma
116,METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification.,YTHDF1,INTERACTS_WITH,m6A,Oral Squamous Cell Carcinoma
116,METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification.,m6A,MAINTAINS,c-Myc,Oral Squamous Cell Carcinoma
116,METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification.,c-Myc,STIMULATES,Tumorigenesis,Oral Squamous Cell Carcinoma
54,"METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes.",METTL3,AFFECTS,m6A,hypoxia/reoxygenation-treated cardiomyocytes
54,"METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes.",ALKBH5,AFFECTS,m6A,hypoxia/reoxygenation-treated cardiomyocytes
54,"METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes.",m6A,LOCATES,TFEB mRNA,hypoxia/reoxygenation-treated cardiomyocytes
54,"METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes.",TFEB mRNA,AFFECTS,hypoxia/reoxygenation-treated cardiomyocytes,hypoxia/reoxygenation-treated cardiomyocytes
286,Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.,ALKBH5,INHIBITS,m6A,KRAS mutation/LKB1 loss lung cancer
286,Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.,m6A,COMPLICATES,oncological behavior,KRAS mutation/LKB1 loss lung cancer
208,ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2alpha-Mediated Glycolysis.,ALKBH5,INHIBITS,Proliferation,Bladder Cancer Cells
208,ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2alpha-Mediated Glycolysis.,ALKBH5,STIMULATES,Cisplatin,Bladder Cancer Cells
208,ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2alpha-Mediated Glycolysis.,ALKBH5,AFFECTS,m6A-CK2alpha-Mediated Glycolysis,Bladder Cancer Cells
208,ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2alpha-Mediated Glycolysis.,m6A-CK2alpha-Mediated Glycolysis,INHIBITS,Proliferation,Bladder Cancer Cells
208,ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2alpha-Mediated Glycolysis.,m6A-CK2alpha-Mediated Glycolysis,STIMULATES,Cisplatin,Bladder Cancer Cells
66,METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.,METTL3,STIMULATES,Tumor Progression,Colorectal Carcinoma
66,METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.,METTL3,AFFECTS,m6A,Colorectal Carcinoma
66,METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.,IGF2BP2,INTERACTS_WITH,m6A,Colorectal Carcinoma
66,METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.,m6A,STIMULATES,Tumor Progression,Colorectal Carcinoma
142,FTO regulates ocular angiogenesis via m6A-YTHDF2-dependent mechanism.,FTO,AFFECTS,Angiogenesis,Ocular
142,FTO regulates ocular angiogenesis via m6A-YTHDF2-dependent mechanism.,FTO,AFFECTS,m6A,Ocular
142,FTO regulates ocular angiogenesis via m6A-YTHDF2-dependent mechanism.,YTHDF2,INTERACTS_WITH,m6A,Ocular
142,FTO regulates ocular angiogenesis via m6A-YTHDF2-dependent mechanism.,m6A,AFFECTS,Angiogenesis,Ocular
150,circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m6A-YTHDF3-Zeb1.,circ_KIAA1429,STIMULATES,Advancement,Hepatocellular Carcinoma
150,circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m6A-YTHDF3-Zeb1.,circ_KIAA1429,AFFECTS,m6A-YTHDF3-Zeb1,Hepatocellular Carcinoma
150,circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m6A-YTHDF3-Zeb1.,m6A-YTHDF3-Zeb1,STIMULATES,Advancement,Hepatocellular Carcinoma
278,METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma.,METTL3,AFFECTS,m6A,IDH-wildtype glioma
278,METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma.,HuR,INTERACTS_WITH,m6A,IDH-wildtype glioma
278,METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma.,m6A,MAINTAINS,MALAT1,IDH-wildtype glioma
278,METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma.,METTL3,STIMULATES,NF-kappaB,IDH-wildtype glioma
278,METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma.,NF-kappaB,STIMULATES,Malignant Progression,IDH-wildtype glioma
333,"The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.",METTL3,AFFECTS,epithelial-mesenchymal transition,Breast Cancer
333,"The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.",METTL3,AFFECTS,migration,Breast Cancer
333,"The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.",METTL3,AFFECTS,invasion,Breast Cancer
333,"The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.",METTL3,AFFECTS,MALAT1/miR-26b/HMGA2 axis,Breast Cancer
333,"The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.",MALAT1/miR-26b/HMGA2 axis,AFFECTS,epithelial-mesenchymal transition,Breast Cancer
333,"The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.",MALAT1/miR-26b/HMGA2 axis,AFFECTS,migration,Breast Cancer
333,"The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.",MALAT1/miR-26b/HMGA2 axis,AFFECTS,invasion,Breast Cancer
49,RNA m6A methyltransferase METTL3 regulates invasiveness of melanoma cells by matrix metallopeptidase 2.,METTL3,AFFECTS,Invasiveness,Melanoma
49,RNA m6A methyltransferase METTL3 regulates invasiveness of melanoma cells by matrix metallopeptidase 2.,METTL3,AFFECTS,Matrix Metallopeptidase 2,Melanoma
49,RNA m6A methyltransferase METTL3 regulates invasiveness of melanoma cells by matrix metallopeptidase 2.,Matrix Metallopeptidase 2,AFFECTS,Invasiveness,Melanoma
384,METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner,METTL14,INHIBITS,malignant progression,oral squamous cell carcinoma
384,METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner,METTL14,AFFECTS,m6A,oral squamous cell carcinoma
384,METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner,IGF2BP2,INTERACTS_WITH,m6A,oral squamous cell carcinoma
384,METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner,m6A,INTERACTS_WITH,RB1CC1,oral squamous cell carcinoma
384,METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner,RB1CC1,INHIBITS,malignant progression,oral squamous cell carcinoma
221,m6A deposition is regulated by PRMT1-mediated arginine methylation of METTL14 in its disordered C-terminal region.,PRMT1,AFFECTS,arginine methylation,Null
221,m6A deposition is regulated by PRMT1-mediated arginine methylation of METTL14 in its disordered C-terminal region.,arginine methylation,LOCATES,METTL14,Null
221,m6A deposition is regulated by PRMT1-mediated arginine methylation of METTL14 in its disordered C-terminal region.,METTL14,AFFECTS,m6A,Null
351,METTL3-Mediated lncRNA m6A Modification in the Osteogenic Differentiation of Human Adipose-Derived Stem Cells Induced by NEL-Like 1 Protein.,METTL3,AFFECTS,m6A,Human Adipose-Derived Stem Cells
351,METTL3-Mediated lncRNA m6A Modification in the Osteogenic Differentiation of Human Adipose-Derived Stem Cells Induced by NEL-Like 1 Protein.,m6A,LOCATES,lncRNA,Human Adipose-Derived Stem Cells
351,METTL3-Mediated lncRNA m6A Modification in the Osteogenic Differentiation of Human Adipose-Derived Stem Cells Induced by NEL-Like 1 Protein.,lncRNA,AFFECTS,osteogenic differentiation,Human Adipose-Derived Stem Cells
351,METTL3-Mediated lncRNA m6A Modification in the Osteogenic Differentiation of Human Adipose-Derived Stem Cells Induced by NEL-Like 1 Protein.,NEL-Like 1 Protein,CAUSES,osteogenic differentiation,Human Adipose-Derived Stem Cells
75,MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62.,MiR-4429,PREVENTS,Progression,Gastric Cancer
75,MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62.,MiR-4429,INTERACTS_WITH,METTL3,Gastric Cancer
75,MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62.,METTL3,INHIBITS,SEC62,Gastric Cancer
75,MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62.,m6A,AFFECTS,SEC62,Gastric Cancer
75,MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62.,SEC62,AFFECTS,Progression,Gastric Cancer
234,Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer.,Dummy,AFFECTS,SNHG3/miR-186-5p,Esophageal Cancer
234,Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer.,SNHG3/miR-186-5p,INHIBITS,METTL3,Esophageal Cancer
234,Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer.,METTL3,AUGMENTS,m6A,Esophageal Cancer
234,Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer.,platinium treatment,AUGMENTS,m6A,Esophageal Cancer
81,Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.,dummy,STIMULATES,METTL3,Colorectal Cancer
81,Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.,METTL3,STIMULATES,Metastasis,Colorectal Cancer
81,Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.,METTL3,AFFECTS,miR-1246/SPRED2/MAPK signaling pathway,Colorectal Cancer
81,Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.,miR-1246/SPRED2/MAPK signaling pathway,STIMULATES,Metastasis,Colorectal Cancer
217,Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m6A/p21 pathway.,Metformin,MANIFESTS,antiproliferation activity,Breast Cancer
217,Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m6A/p21 pathway.,Metformin,AFFECTS,miR-483-3p/METTL3/m6A/p21 pathway,Breast Cancer
217,Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m6A/p21 pathway.,miR-483-3p/METTL3/m6A/p21 pathway,MANIFESTS,antiproliferation activity,Breast Cancer
22,FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting beta-catenin through mRNA demethylation.,FTO,AFFECTS,mRNA demethylation,Cervical Squamous Cell Carcinoma (CSCC)
22,FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting beta-catenin through mRNA demethylation.,mRNA demethylation,INTERACTS_WITH,beta-catenin,Cervical Squamous Cell Carcinoma (CSCC)
22,FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting beta-catenin through mRNA demethylation.,beta-catenin,AFFECTS,Chemo-radiotherapy resistance,Cervical Squamous Cell Carcinoma (CSCC)
22,FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting beta-catenin through mRNA demethylation.,FTO,AFFECTS,Chemo-radiotherapy resistance,Cervical Squamous Cell Carcinoma (CSCC)
320,RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.,RBM15,AFFECTS,N6-methyladenosine,COVID-19
320,RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.,N6-methyladenosine,LOCATES,multitarget genes,COVID-19
320,RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.,multitarget genes,AFFECTS,Severity,COVID-19
320,RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.,RBM15,AFFECTS,Severity,COVID-19
139,N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression.,METTL3,STIMULATES,Cell Proliferation,Colorectal Cancer
139,N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression.,METTL3,AUGMENTS,MYC,Colorectal Cancer
139,N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression.,MYC,STIMULATES,Cell Proliferation,Colorectal Cancer
126,The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.,METTL3,STIMULATES,Development,Prostate Carcinoma
126,The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.,METTL3,STIMULATES,progression,Prostate Carcinoma
126,The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.,METTL3,AFFECTS,MYC,Prostate Carcinoma
126,The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.,MYC,STIMULATES,Development,Prostate Carcinoma
126,The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation.,MYC,STIMULATES,progression,Prostate Carcinoma
31,m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression.,FTO,STIMULATES,Tumor Progression,Lung Squamous Cell Carcinoma
31,m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression.,FTO,AFFECTS,MZF1,Lung Squamous Cell Carcinoma
31,m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression.,MZF1,STIMULATES,Tumor Progression,Lung Squamous Cell Carcinoma
1,FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis.,FTO,CONVERTS_TO,N6-methyladenosine,Adipogenesis
1,FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis.,N6-methyladenosine,AFFECTS,mRNA splicing,Adipogenesis
1,FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis.,N6-methyladenosine,CAUSES,Adipogenesis,Adipogenesis
306,m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer.,FTO,CAUSES,NELL2,Non-small cell lung cancer
306,m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer.,FTO,CAUSES,Metastasis,Non-small cell lung cancer
306,m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer.,FTO,INHIBITS,m6A,Non-small cell lung cancer
306,m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer.,m6A,LOCATES,E2F1,Non-small cell lung cancer
306,m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer.,E2F1,AFFECTS,NELL2,Non-small cell lung cancer
310,YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-kappaB and promote the malignant progression of glioma.,YTHDF2,INHIBITS,UBXN1,Glioma
310,YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-kappaB and promote the malignant progression of glioma.,YTHDF2,INTERACTS_WITH,m6A,Glioma
310,YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-kappaB and promote the malignant progression of glioma.,METTL3,AFFECTS,m6A,Glioma
310,YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-kappaB and promote the malignant progression of glioma.,UBXN1,STIMULATES,NF-kappaB,Glioma
310,YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-kappaB and promote the malignant progression of glioma.,NF-kappaB,STIMULATES,Malignant Progression,Glioma
310,YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-kappaB and promote the malignant progression of glioma.,m6A,AFFECTS,UBXN1,Glioma
294,METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway.,METTL3,AFFECTS,m6A Methylation,Muscle
294,METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway.,m6A Methylation,AFFECTS,Muscle Stem Cells,Muscle
294,METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway.,m6A Methylation,AFFECTS,Muscle Regeneration,Muscle
294,METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway.,METTL3,AFFECTS,Notch Signaling Pathway,Muscle
294,METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway.,Notch Signaling Pathway,AFFECTS,Muscle Stem Cells,Muscle
294,METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway.,Notch Signaling Pathway,AFFECTS,Muscle Regeneration,Muscle
270,Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.,EED,CONVERTS_TO,microRNA-338-5p,Gastric Cancer
270,Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.,microRNA-338-5p,STIMULATES,METTL3,Gastric Cancer
270,Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.,METTL3,AFFECTS,translation,Gastric Cancer
270,Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.,translation,PROCESS_OF,CDCP1,Gastric Cancer
353,FTO-mediated demethylation of GADD45B promotes myogenesis through the activation of p38 MAPK pathway.,FTO,CONVERTS_TO,GADD45B,Null
353,FTO-mediated demethylation of GADD45B promotes myogenesis through the activation of p38 MAPK pathway.,GADD45B,STIMULATES,myogenesis,Null
353,FTO-mediated demethylation of GADD45B promotes myogenesis through the activation of p38 MAPK pathway.,GADD45B,STIMULATES,p38 MAPK pathway,Null
353,FTO-mediated demethylation of GADD45B promotes myogenesis through the activation of p38 MAPK pathway.,p38 MAPK pathway,STIMULATES,myogenesis,Null
68,m6A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways.,METTL3,INHIBITS,Proliferation,Colorectal Cancer
68,m6A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways.,METTL3,INHIBITS,Migration,Colorectal Cancer
68,m6A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways.,METTL3,AFFECTS,p38/ERK pathways,Colorectal Cancer
68,m6A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways.,p38/ERK pathways,INHIBITS,Proliferation,Colorectal Cancer
68,m6A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways.,p38/ERK pathways,INHIBITS,Migration,Colorectal Cancer
168,microRNA-421-3p prevents inflammatory response in cerebral ischemia/reperfusion injury through targeting m6A Reader YTHDF1 to inhibit p65 mRNA translation.,microRNA-421-3p,PREVENTS,Inflammatory Response,Cerebral Ischemia/Reperfusion Injury
168,microRNA-421-3p prevents inflammatory response in cerebral ischemia/reperfusion injury through targeting m6A Reader YTHDF1 to inhibit p65 mRNA translation.,microRNA-421-3p,INTERACTS_WITH,YTHDF1,Cerebral Ischemia/Reperfusion Injury
168,microRNA-421-3p prevents inflammatory response in cerebral ischemia/reperfusion injury through targeting m6A Reader YTHDF1 to inhibit p65 mRNA translation.,YTHDF1,INHIBITS,p65,Cerebral Ischemia/Reperfusion Injury
168,microRNA-421-3p prevents inflammatory response in cerebral ischemia/reperfusion injury through targeting m6A Reader YTHDF1 to inhibit p65 mRNA translation.,p65,PREVENTS,Inflammatory Response,Cerebral Ischemia/Reperfusion Injury
137,RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.,ALKBH5,PREVENTS,Progression,Pancreatic Cancer
137,RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.,ALKBH5,AFFECTS,m6A,Pancreatic Cancer
137,RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.,YTHDF2,INTERACTS_WITH,m6A,Pancreatic Cancer
137,RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.,m6A,STIMULATES,PER1,Pancreatic Cancer
137,RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.,PER1,PREVENTS,Progression,Pancreatic Cancer
191,DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-alpha in alcohol-induced kidney injury.,dummy,CONVERTS_TO,FTO,Alcohol-induced kidney injury
191,DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-alpha in alcohol-induced kidney injury.,FTO,STIMULATES,Renal Inflammation,Alcohol-induced kidney injury
191,DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-alpha in alcohol-induced kidney injury.,FTO,AUGMENTS,m6A,Alcohol-induced kidney injury
191,DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-alpha in alcohol-induced kidney injury.,m6A,LOCATES,PPAR-alpha,Alcohol-induced kidney injury
191,DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-alpha in alcohol-induced kidney injury.,PPAR-alpha,STIMULATES,Renal Inflammation,Alcohol-induced kidney injury
346,KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner.,KIAA1429,CONVERTS_TO,m6A,Aortic Dissection
346,KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner.,ALKBH5,CONVERTS_TO,m6A,Aortic Dissection
346,KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner.,m6A,AFFECTS,Pri-miR-143-3p,Aortic Dissection
346,KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner.,Pri-miR-143-3p,AFFECTS,Progression,Aortic Dissection
346,KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner.,KIAA1429,AFFECTS,Progression,Aortic Dissection
346,KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner.,ALKBH5,AFFECTS,Progression,Aortic Dissection
246,Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375.,Mettl14,AFFECTS,m6A,Spinal Cord Injury
246,Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375.,m6A,AFFECTS,neuron apoptosis,Spinal Cord Injury
246,Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375.,m6A,AFFECTS,pri-mir-375,Spinal Cord Injury
246,Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375.,pri-mir-375,CONVERTS_TO,miR-375,Spinal Cord Injury
246,Mettl14-mediated m6A modification modulates neuron apoptosis during the repair of spinal cord injury by regulating the transformation from pri-mir-375 to miR-375.,miR-375,AFFECTS,neuron apoptosis,Spinal Cord Injury
367,METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing.,METTL14,INHIBITS,Progression,Colorectal Cancer
367,METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing.,METTL14,AFFECTS,N6-Methyladenosine,Colorectal Cancer
367,METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing.,N6-Methyladenosine,LOCATES,miR-375,Colorectal Cancer
367,METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing.,miR-375,INHIBITS,Progression,Colorectal Cancer
343,The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma.,METTL14,AFFECTS,N6-Methyladenosine,Stomach Adenocarcinoma
343,The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma.,N6-Methyladenosine,LOCATES,PTEN,Stomach Adenocarcinoma
343,The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma.,PTEN,INHIBITS,Tumor Growth,Stomach Adenocarcinoma
343,The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma.,PTEN,INHIBITS,Metastasis,Stomach Adenocarcinoma
24,FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation.,FTO,INHIBITS,Mitochondria,Null
24,FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation.,FTO,STIMULATES,Hepatic fat accumulation,Null
24,FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation.,FTO,CONVERTS_TO,RNA,Null
24,FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation.,RNA,INHIBITS,Mitochondria,Null
24,FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation.,RNA,STIMULATES,Hepatic fat accumulation,Null
299,The RNA demethylase ALKBH5 promotes osteoblast differentiation by modulating Runx2 mRNA stability.,ALKBH5,STIMULATES,differentiation,Osteoblast
299,The RNA demethylase ALKBH5 promotes osteoblast differentiation by modulating Runx2 mRNA stability.,ALKBH5,DISRUPTS,Runx2,Osteoblast
299,The RNA demethylase ALKBH5 promotes osteoblast differentiation by modulating Runx2 mRNA stability.,Runx2,STIMULATES,differentiation,Osteoblast
196,The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function.,YTHDC2,INHIBITS,Tumorigenesis,Lung Adenocarcinoma
196,The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function.,YTHDC2,INHIBITS,SLC7A11,Lung Adenocarcinoma
196,The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function.,SLC7A11,INHIBITS,Tumorigenesis,Lung Adenocarcinoma
339,RNA m6A methyltransferase METTL3 promotes colorectal cancer cell proliferation and invasion by regulating Snail expression.,METTL3,STIMULATES,cell proliferation,Colorectal Cancer
339,RNA m6A methyltransferase METTL3 promotes colorectal cancer cell proliferation and invasion by regulating Snail expression.,METTL3,STIMULATES,Invasion,Colorectal Cancer
339,RNA m6A methyltransferase METTL3 promotes colorectal cancer cell proliferation and invasion by regulating Snail expression.,METTL3,AFFECTS,Snail,Colorectal Cancer
339,RNA m6A methyltransferase METTL3 promotes colorectal cancer cell proliferation and invasion by regulating Snail expression.,Snail,STIMULATES,cell proliferation,Colorectal Cancer
339,RNA m6A methyltransferase METTL3 promotes colorectal cancer cell proliferation and invasion by regulating Snail expression.,Snail,STIMULATES,Invasion,Colorectal Cancer
143,METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.,METTL14,AFFECTS,N6-methyladenosine,Colorectal Cancer
143,METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.,N6-methyladenosine,LOCATES,SOX4,Colorectal Cancer
143,METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.,SOX4,INHIBITS,Tumor Metastasis,Colorectal Cancer
39,Methylation of Structured RNA by the m6A Writer METTL16 Is Essential for Mouse Embryonic Development.,METTL16,AFFECTS,Methylation of Structured RNA,mouse embryo
39,Methylation of Structured RNA by the m6A Writer METTL16 Is Essential for Mouse Embryonic Development.,Methylation of Structured RNA,CAUSES,Development,mouse embryo
281,m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease.,ALKBH5,INHIBITS,proliferation,Hirschsprung's disease
281,m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease.,ALKBH5,INHIBITS,migration,Hirschsprung's disease
281,m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease.,proliferation,LOCATES,enteric neural crest cells,Hirschsprung's disease
281,m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease.,migration,LOCATES,enteric neural crest cells,Hirschsprung's disease
281,m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease.,ALKBH5,AFFECTS,TAGLN,Hirschsprung's disease
281,m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease.,TAGLN,INHIBITS,proliferation,Hirschsprung's disease
281,m6A demethylase ALKBH5 suppresses proliferation and migration of enteric neural crest cells by regulating TAGLN in Hirschsprung's disease.,TAGLN,INHIBITS,migration,Hirschsprung's disease
192,The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6/NF-kappaB pathway.,METTL3,STIMULATES,inflammation,LPS-induced microglia
192,The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6/NF-kappaB pathway.,METTL3,AFFECTS,TRAF6/NF-kappaB pathway,LPS-induced microglia
192,The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6/NF-kappaB pathway.,TRAF6/NF-kappaB pathway,STIMULATES,inflammation,LPS-induced microglia
257,The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner.,YTHDF1,STIMULATES,Tumorigenesis,Gastric Cancer
257,The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner.,YTHDF1,STIMULATES,Metastasis,Gastric Cancer
257,The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner.,YTHDF1,INTERACTS_WITH,m6A,Gastric Cancer
257,The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner.,m6A,AFFECTS,USP14,Gastric Cancer
257,The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner.,USP14,STIMULATES,Tumorigenesis,Gastric Cancer
257,The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner.,USP14,STIMULATES,Metastasis,Gastric Cancer
100,m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling.,ALKBH5,INHIBITS,Tumorigenesis,Pancreatic Cancer
100,m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling.,ALKBH5,INHIBITS,WIF-1,Pancreatic Cancer
100,m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling.,ALKBH5,AFFECTS,Wnt signaling,Pancreatic Cancer
100,m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling.,WIF-1,INHIBITS,Tumorigenesis,Pancreatic Cancer
100,m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling.,Wnt signaling,INHIBITS,Tumorigenesis,Pancreatic Cancer
252,METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt/beta-catenin pathway.,METTL3,INHIBITS,Proliferative vitreoretinopathy,retinal pigment epithelial cells
252,METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt/beta-catenin pathway.,METTL3,INHIBITS,Epithelial-mesenchymal transition,retinal pigment epithelial cells
252,METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt/beta-catenin pathway.,METTL3,USES,wnt/beta-catenin pathway,retinal pigment epithelial cells
252,METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt/beta-catenin pathway.,wnt/beta-catenin pathway,INHIBITS,Proliferative vitreoretinopathy,retinal pigment epithelial cells
252,METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt/beta-catenin pathway.,wnt/beta-catenin pathway,INHIBITS,Epithelial-mesenchymal transition,retinal pigment epithelial cells
95,m6A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2.,m6A,STIMULATES,Translation,Null
95,m6A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2.,YTHDC2,INTERACTS_WITH,m6A,Null
298,KAT1 triggers YTHDF2-mediated ITGB1 mRNA instability to alleviate the progression of diabetic retinopathy.,KAT1,CAUSES,YTHDF2,Diabetic Retinopathy
298,KAT1 triggers YTHDF2-mediated ITGB1 mRNA instability to alleviate the progression of diabetic retinopathy.,YTHDF2,AFFECTS,ITGB1,Diabetic Retinopathy
298,KAT1 triggers YTHDF2-mediated ITGB1 mRNA instability to alleviate the progression of diabetic retinopathy.,ITGB1,INHIBITS,Progression,Diabetic Retinopathy
301,Methyltransferase-like 3 contributes to inflammatory pain by targeting TET1 in YTHDF2-dependent manner.,Methyltransferase-like 3,AFFECTS,Inflammatory Pain,Null
301,Methyltransferase-like 3 contributes to inflammatory pain by targeting TET1 in YTHDF2-dependent manner.,YTHDF2,INTERACTS_WITH,TET1,Null
301,Methyltransferase-like 3 contributes to inflammatory pain by targeting TET1 in YTHDF2-dependent manner.,Methyltransferase-like 3,INTERACTS_WITH,TET1,Null
301,Methyltransferase-like 3 contributes to inflammatory pain by targeting TET1 in YTHDF2-dependent manner.,TET1,AFFECTS,Inflammatory Pain,Null
111,m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.,ALKBH5,INHIBITS,Tumor growth,NSCLC
111,m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.,ALKBH5,INHIBITS,Metastasis,NSCLC
111,m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.,ALKBH5,INHIBITS,YAP,NSCLC
111,m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.,YTHDFs,AFFECTS,YAP,NSCLC
111,m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.,ALKBH5,INHIBITS,YAP,NSCLC
111,m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.,miR-107,AFFECTS,YAP,NSCLC
111,m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.,LATS2,AFFECTS,YAP,NSCLC
111,m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.,YAP,INHIBITS,Tumor growth,NSCLC
111,m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.,YAP,INHIBITS,Metastasis,NSCLC
226,METTL3-mediated m6A modification of ZBTB4 mRNA is involved in the smoking-induced EMT in cancer of the lung.,METTL3,AFFECTS,m6A,cancer of the lung
226,METTL3-mediated m6A modification of ZBTB4 mRNA is involved in the smoking-induced EMT in cancer of the lung.,m6A,LOCATES,ZBTB4,cancer of the lung
226,METTL3-mediated m6A modification of ZBTB4 mRNA is involved in the smoking-induced EMT in cancer of the lung.,ZBTB4,ASSOCIATED_WITH,EMT,cancer of the lung
108,Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.,dummy,INHIBITS,METTL3,Osteosarcoma
108,Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.,METTL3,INHIBITS,Proliferation,Osteosarcoma
108,Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.,METTL3,INHIBITS,Invasion,Osteosarcoma
108,Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.,METTL3,AFFECTS,ATAD2,Osteosarcoma
108,Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.,ATAD2,INHIBITS,Proliferation,Osteosarcoma
108,Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2.,ATAD2,INHIBITS,Invasion,Osteosarcoma
283,The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma.,METTL3,AFFECTS,Autophagy,Seminoma
283,The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma.,METTL3,AFFECTS,sensitivity,Seminoma
283,The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma.,METTL3,INTERACTS_WITH,ATG5,Seminoma
283,The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma.,ATG5,AFFECTS,Autophagy,Seminoma
283,The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma.,ATG5,AFFECTS,sensitivity,Seminoma
233,METTL3-mediated m6A methylation negatively modulates autophagy to support porcine blastocyst development.,METTL3,AFFECTS,m6A,Porcine Blastocyst
233,METTL3-mediated m6A methylation negatively modulates autophagy to support porcine blastocyst development.,m6A,INHIBITS,Autophagy,Porcine Blastocyst
233,METTL3-mediated m6A methylation negatively modulates autophagy to support porcine blastocyst development.,Autophagy,STIMULATES,Development,Porcine Blastocyst
80,N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.,METTL3,STIMULATES,Progression,Breast Cancer
80,N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.,METTL3,INTERACTS_WITH,Bcl-2,Breast Cancer
80,N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.,Bcl-2,STIMULATES,Progression,Breast Cancer
64,EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis.,METTL14,CONVERTS_TO,EBV epitranscriptome,Null
64,EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis.,EBV epitranscriptome,CAUSES,Tumorigenesis,Null
311,N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2.,FTO,CAUSES,Dysfunctions,Ovarian Granulosa Cells
311,N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2.,FTO,STIMULATES,Flotillin 2,Ovarian Granulosa Cells
311,N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2.,Flotillin 2,CAUSES,Dysfunctions,Ovarian Granulosa Cells
8,m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.,ALKBH5,MAINTAINS,Tumorigenicity,Glioblastoma Stem-like Cells
8,m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.,ALKBH5,MAINTAINS,FOXM1,Glioblastoma Stem-like Cells
8,m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.,ALKBH5,MAINTAINS,Cell Proliferation,Glioblastoma Stem-like Cells
8,m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.,FOXM1,MAINTAINS,Tumorigenicity,Glioblastoma Stem-like Cells
8,m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.,Cell Proliferation,MAINTAINS,Tumorigenicity,Glioblastoma Stem-like Cells
267,Exposure to constant light impairs cognition with FTO inhibition and m6A-dependent TrkappaB repression in mouse hippocampus.,dummy,ADMINISTERED_TO,constant light,Mouse Hippocampus
267,Exposure to constant light impairs cognition with FTO inhibition and m6A-dependent TrkappaB repression in mouse hippocampus.,constant light,INHIBITS,Cognition,Mouse Hippocampus
267,Exposure to constant light impairs cognition with FTO inhibition and m6A-dependent TrkappaB repression in mouse hippocampus.,constant light,INHIBITS,FTO,Mouse Hippocampus
267,Exposure to constant light impairs cognition with FTO inhibition and m6A-dependent TrkappaB repression in mouse hippocampus.,constant light,AFFECTS,m6A,Mouse Hippocampus
267,Exposure to constant light impairs cognition with FTO inhibition and m6A-dependent TrkappaB repression in mouse hippocampus.,m6A,INHIBITS,TrkappaB,Mouse Hippocampus
267,Exposure to constant light impairs cognition with FTO inhibition and m6A-dependent TrkappaB repression in mouse hippocampus.,FTO,INHIBITS,Cognition,Mouse Hippocampus
267,Exposure to constant light impairs cognition with FTO inhibition and m6A-dependent TrkappaB repression in mouse hippocampus.,TrkappaB,INHIBITS,Cognition,Mouse Hippocampus
273,Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance.,Tumors,USES,FTO,Null
273,Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance.,FTO,AFFECTS,Glycolytic metabolism,Tumors
273,Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance.,Glycolytic metabolism,PREVENTS,Immune surveillance,Tumors
97,RNA m6A Methyltransferase METTL3 Promotes The Growth Of Prostate Cancer By Regulating Hedgehog Pathway.,METTL3,STIMULATES,Growth,Prostate Cancer
97,RNA m6A Methyltransferase METTL3 Promotes The Growth Of Prostate Cancer By Regulating Hedgehog Pathway.,METTL3,AFFECTS,Hedgehog Pathway,Prostate Cancer
97,RNA m6A Methyltransferase METTL3 Promotes The Growth Of Prostate Cancer By Regulating Hedgehog Pathway.,Hedgehog Pathway,STIMULATES,Growth,Prostate Cancer
240,METTL3-mediated m6A modification regulates cell cycle progression of dental pulp stem cells.,METTL3,AFFECTS,m6A,Dental Pulp Stem Cells
240,METTL3-mediated m6A modification regulates cell cycle progression of dental pulp stem cells.,m6A,AFFECTS,Cell cycle progression,Dental Pulp Stem Cells
117,Hypoxia Promotes Vascular Smooth Muscle Cell (VSMC) Differentiation of Adipose-Derived Stem Cell (ADSC) by Regulating Mettl3 and Paracrine Factors.,Hypoxia,STIMULATES,VSMC Differentiation,Adipose-Derived Stem Cell (ADSC)
117,Hypoxia Promotes Vascular Smooth Muscle Cell (VSMC) Differentiation of Adipose-Derived Stem Cell (ADSC) by Regulating Mettl3 and Paracrine Factors.,Hypoxia,AFFECTS,Mettl3,Adipose-Derived Stem Cell (ADSC)
117,Hypoxia Promotes Vascular Smooth Muscle Cell (VSMC) Differentiation of Adipose-Derived Stem Cell (ADSC) by Regulating Mettl3 and Paracrine Factors.,Hypoxia,AFFECTS,Paracrine Factors,Adipose-Derived Stem Cell (ADSC)
117,Hypoxia Promotes Vascular Smooth Muscle Cell (VSMC) Differentiation of Adipose-Derived Stem Cell (ADSC) by Regulating Mettl3 and Paracrine Factors.,Mettl3,STIMULATES,VSMC Differentiation,Adipose-Derived Stem Cell (ADSC)
117,Hypoxia Promotes Vascular Smooth Muscle Cell (VSMC) Differentiation of Adipose-Derived Stem Cell (ADSC) by Regulating Mettl3 and Paracrine Factors.,Paracrine Factors,STIMULATES,VSMC Differentiation,Adipose-Derived Stem Cell (ADSC)
220,ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1.,ALKBH5,AFFECTS,Cardiomyocyte Proliferation,Null
220,ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1.,ALKBH5,AFFECTS,heart regeneration,Null
220,ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1.,ALKBH5,CONVERTS_TO,YTHDF1,Null
220,ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1.,YTHDF1,AFFECTS,Cardiomyocyte Proliferation,Null
220,ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1.,YTHDF1,AFFECTS,heart regeneration,Null
120,METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway.,METTL3,STIMULATES,Progression,Gastric Cancer
120,METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway.,METTL3,INTERACTS_WITH,MYC Pathway,Gastric Cancer
120,METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway.,MYC Pathway,STIMULATES,Progression,Gastric Cancer
90,The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-kappaB signaling.,METTL3,AFFECTS,Osteogenic Differentiation,osteogenic differentiation
90,The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-kappaB signaling.,METTL3,AFFECTS,NF-kappaB signaling,osteogenic differentiation
90,The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-kappaB signaling.,ALKBH5,AFFECTS,Osteogenic Differentiation,osteogenic differentiation
90,The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-kappaB signaling.,ALKBH5,AFFECTS,NF-kappaB signaling,osteogenic differentiation
90,The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-kappaB signaling.,NF-kappaB signaling,AFFECTS,Osteogenic Differentiation,osteogenic differentiation
184,m6A methyltransferase METTL3 promotes retinoblastoma progression via PI3K/AKT/mTOR pathway.,METTL3,STIMULATES,Progression,Retinoblastoma
184,m6A methyltransferase METTL3 promotes retinoblastoma progression via PI3K/AKT/mTOR pathway.,METTL3,STIMULATES,PI3K/AKT/mTOR pathway,Retinoblastoma
184,m6A methyltransferase METTL3 promotes retinoblastoma progression via PI3K/AKT/mTOR pathway.,PI3K/AKT/mTOR pathway,STIMULATES,Progression,Retinoblastoma
345,m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.,FTO,INHIBITS,Tumorigenesis,Pancreatic Cancer
345,m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.,FTO,CONVERTS_TO,PJA2,Pancreatic Cancer
345,m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.,FTO,INHIBITS,Wnt signaling,Pancreatic Cancer
345,m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.,PJA2,INHIBITS,Tumorigenesis,Pancreatic Cancer
345,m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.,Wnt signaling,INHIBITS,Tumorigenesis,Pancreatic Cancer
341,The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG.,FTO,STIMULATES,Osteogenesis,mesenchymal stem cells
341,The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG.,FTO,INHIBITS,PPARG,mesenchymal stem cells
341,The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG.,PPARG,INHIBITS,Osteogenesis,mesenchymal stem cells
101,METTL3 regulates inflammatory pain by modulating m6A-dependent pri-miR-365-3p processing.,METTL3,AFFECTS,Inflammatory Pain,Null
101,METTL3 regulates inflammatory pain by modulating m6A-dependent pri-miR-365-3p processing.,METTL3,AFFECTS,m6A,Null
101,METTL3 regulates inflammatory pain by modulating m6A-dependent pri-miR-365-3p processing.,m6A,AFFECTS,pri-miR-365-3p processing,Null
101,METTL3 regulates inflammatory pain by modulating m6A-dependent pri-miR-365-3p processing.,pri-miR-365-3p processing,AFFECTS,Inflammatory Pain,Null
28,Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)d.,Zc3h13/Flacc,CAUSES,adenosine methylation,Null
28,Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)d.,Zc3h13/Flacc,ASSOCIATED_WITH,Rbm15/Spenito,Null
28,Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)d.,Rbm15/Spenito,INTERACTS_WITH,Wtap/Fl(2)d,Null
28,Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)d.,Wtap/Fl(2)d,AFFECTS,adenosine methylation,Null
349,RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.,FTO,STIMULATES,Osteoporosis,Osteoporosis
349,RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.,FTO,CONVERTS_TO,Runx2 mRNA,Osteoporosis
349,RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.,FTO,INHIBITS,Osteogenic differentiation,Osteoporosis
349,RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.,Runx2 mRNA,AFFECTS,Osteoporosis,Osteoporosis
349,RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.,Osteogenic differentiation,AFFECTS,Osteoporosis,Osteoporosis
115,METTL3/YTHDF2 m6A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.,METTL3/YTHDF2 m6A axis,STIMULATES,Tumorigenesis,Bladder Cancer
115,METTL3/YTHDF2 m6A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.,METTL3/YTHDF2 m6A axis,INHIBITS,SETD7,Bladder Cancer
115,METTL3/YTHDF2 m6A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.,METTL3/YTHDF2 m6A axis,INHIBITS,KLF4,Bladder Cancer
115,METTL3/YTHDF2 m6A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.,SETD7,INHIBITS,Tumorigenesis,Bladder Cancer
115,METTL3/YTHDF2 m6A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.,KLF4,INHIBITS,Tumorigenesis,Bladder Cancer
17,Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control.,METTL3,MAINTAINS,Myeloid Leukaemia,Myeloid Leukaemia
17,Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control.,METTL3,AFFECTS,m6A,Myeloid Leukaemia
17,Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control.,m6A,AFFECTS,translation,Myeloid Leukaemia
17,Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control.,m6A,MAINTAINS,Myeloid Leukaemia,Myeloid Leukaemia
113,METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.,METTL14,INHIBITS,Proliferation,Colorectal Cancer
113,METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.,METTL14,INHIBITS,Metastasis,Colorectal Cancer
113,METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.,METTL14,INHIBITS,XIST,Colorectal Cancer
113,METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.,XIST,STIMULATES,Proliferation,Colorectal Cancer
113,METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.,XIST,STIMULATES,Metastasis,Colorectal Cancer
86,Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3.,GAS5,INHIBITS,Progression,Colorectal Cancer
86,Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3.,GAS5,CONVERTS_TO,YAP,Colorectal Cancer
86,Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3.,GAS5,INHIBITS,YAP,Colorectal Cancer
86,Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3.,YAP,INHIBITS,Progression,Colorectal Cancer
86,Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3.,YTHDF3,INHIBITS,GAS5,Colorectal Cancer
71,The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1.,METTL14,STIMULATES,Renal Ischemic Reperfusion Injury,Renal Ischemic Reperfusion Injury
71,The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1.,METTL14,INHIBITS,YAP1,Renal Ischemic Reperfusion Injury
71,The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1.,YAP1,INHIBITS,Renal Ischemic Reperfusion Injury,Renal Ischemic Reperfusion Injury
212,METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5.,METTL3/YTHDF2 m6A axis,STIMULATES,Colorectal Carcinogenesis,Colorectal Carcinogenesis
212,METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5.,METTL3/YTHDF2 m6A axis,INHIBITS,YPEL5,Colorectal Carcinogenesis
212,METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5.,YPEL5,STIMULATES,Colorectal Carcinogenesis,Colorectal Carcinogenesis
197,Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1.,MicroRNA-376c,INHIBITS,Properties,Non-Small Cell Lung Cancer
197,Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1.,MicroRNA-376c,LOCATES,Extracellular Vesicles,Non-Small Cell Lung Cancer
197,Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1.,MicroRNA-376c,INTERACTS_WITH,YTHDF1,Non-Small Cell Lung Cancer
197,Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1.,YTHDF1,AFFECTS,Properties,Non-Small Cell Lung Cancer
110,YTHDF1-mediated translation amplifies Wnt-driven intestinal stemness.,YTHDF1,AFFECTS,Translation,Null
110,YTHDF1-mediated translation amplifies Wnt-driven intestinal stemness.,Translation,AUGMENTS,Wnt-driven intestinal stemness,Null
55,m6A Reader YTHDF2 Regulates LPS-Induced Inflammatory Response.,YTHDF2,AFFECTS,Inflammatory Response,Null
55,m6A Reader YTHDF2 Regulates LPS-Induced Inflammatory Response.,LPS,CAUSES,Inflammatory Response,Null
125,YTHDF2 promotes mitotic entry and is regulated by cell cycle mediators.,YTHDF2,STIMULATES,Mitotic Entry,Null
125,YTHDF2 promotes mitotic entry and is regulated by cell cycle mediators.,Cell Cycle Mediators,AFFECTS,YTHDF2,Null
255,Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma.,dummy,INTERACTS_WITH,SLC3A2 subunit of system XC-,Lung Adenocarcinoma
255,Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma.,SLC3A2 subunit of system XC-,CAUSES,YTHDC2,Lung Adenocarcinoma
255,Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma.,YTHDC2,CAUSES,Ferroptosis,Lung Adenocarcinoma
332,Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.,dummy,INHIBITS,METTL3,Endometriosis
332,Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.,dummy,INHIBITS,m6A,Endometriosis
332,Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.,dummy,INHIBITS,miR126,Endometriosis
332,Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.,METTL3,STIMULATES,migration,Endometriosis
332,Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.,METTL3,STIMULATES,invasion of endometrial stromal cells,Endometriosis
332,Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.,m6A,STIMULATES,migration,Endometriosis
332,Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.,m6A,STIMULATES,invasion of endometrial stromal cells,Endometriosis
332,Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.,miR126,STIMULATES,migration,Endometriosis
332,Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis.,miR126,STIMULATES,invasion of endometrial stromal cells,Endometriosis
82,Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly.,Bi-allelic Variants,LOCATES,METTL5,Autosomal-Recessive Intellectual Disability and Microcephaly
82,Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly.,METTL5,CAUSES,Autosomal-Recessive Intellectual Disability,Autosomal-Recessive Intellectual Disability and Microcephaly
82,Bi-allelic Variants in METTL5 Cause Autosomal-Recessive Intellectual Disability and Microcephaly.,METTL5,CAUSES,Microcephaly,Autosomal-Recessive Intellectual Disability and Microcephaly
362,RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.,FTO,STIMULATES,LINC00022,Esophageal Squamous Cell Carcinoma
362,RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.,LINC00022,STIMULATES,tumorigenesis,Esophageal Squamous Cell Carcinoma
2,Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5.,Meclofenamic acid,INHIBITS,FTO,Null
2,Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5.,Meclofenamic acid,INHIBITS,ALKBH5,Null
275,Small-Molecule Inhibitors of the RNA M6A Demethylases FTO Potently Support the Survival of Dopamine Neurons.,Small-Molecule Inhibitors,PROCESS_OF,FTO,Dopamine Neurons
275,Small-Molecule Inhibitors of the RNA M6A Demethylases FTO Potently Support the Survival of Dopamine Neurons.,Small-Molecule Inhibitors,STIMULATES,Survival,Dopamine Neurons
6,NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation.,NSUN2,AFFECTS,m5C Methylation,Null
6,NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation.,METTL3,AFFECTS,m6A Methylation,Null
6,NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation.,METTL14,AFFECTS,m6A Methylation,Null
6,NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation.,m5C Methylation,AUGMENTS,p21 Translation,Null
6,NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation.,m6A Methylation,AUGMENTS,p21 Translation,Null
300,A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.,HBx,STIMULATES,ALKBH5,Hepatocellular Carcinogenesis
300,A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.,ALKBH5,STIMULATES,HBx,Hepatocellular Carcinogenesis
300,A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.,HBx,STIMULATES,Hepatocellular Carcinogenesis,Hepatocellular Carcinogenesis
300,A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.,ALKBH5,STIMULATES,Hepatocellular Carcinogenesis,Hepatocellular Carcinogenesis
35,FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair.,FTO,AFFECTS,N6-Methyladenosine,Cardiac Remodeling and Repair
35,FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair.,N6-Methyladenosine,AFFECTS,Cardiac Function,Cardiac Remodeling and Repair
89,Binding to m6A RNA promotes YTHDF2-mediated phase separation.,YTHDF2,INTERACTS_WITH,m6A,Null
89,Binding to m6A RNA promotes YTHDF2-mediated phase separation.,m6A,STIMULATES,Phase Separation,Null
144,Early-life m6A RNA demethylation by fat mass and obesity-associated protein (FTO) influences resilience or vulnerability to heat stress later in life.,FTO,CONVERTS_TO,m6A,Heat Stress
144,Early-life m6A RNA demethylation by fat mass and obesity-associated protein (FTO) influences resilience or vulnerability to heat stress later in life.,m6A,AFFECTS,resilience,Heat Stress
144,Early-life m6A RNA demethylation by fat mass and obesity-associated protein (FTO) influences resilience or vulnerability to heat stress later in life.,m6A,AFFECTS,vulnerability,Heat Stress
228,RNA secondary structure dependence in METTL3-METTL14 mRNA methylation is modulated by the N-terminal domain of METTL3.,N-terminal domain of METTL3,AFFECTS,RNA secondary structure dependence in METTL3-METTL14 mRNA methylation,Null
34,m6A Demethylase FTO Regulates Dopaminergic Neurotransmission Deficits Caused by Arsenite.,FTO,AFFECTS,Dopaminergic Neurotransmission Deficits,Dopaminergic Neurotransmission Deficits
34,m6A Demethylase FTO Regulates Dopaminergic Neurotransmission Deficits Caused by Arsenite.,Arsenite,CAUSES,Dopaminergic Neurotransmission Deficits,Dopaminergic Neurotransmission Deficits
253,RNA demethylation by FTO stabilizes the FOXJ1 mRNA for proper motile ciliogenesis.,FTO,MAINTAINS,FOXJ1,Null
253,RNA demethylation by FTO stabilizes the FOXJ1 mRNA for proper motile ciliogenesis.,FOXJ1,AFFECTS,Motile Ciliogenesis,Null
277,METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukemia.,METTL3,AFFECTS,Bone Marrow Mesenchymal Stem Cell Adipogenesis,Acute Myeloid Leukemia
277,METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukemia.,Bone Marrow Mesenchymal Stem Cell Adipogenesis,STIMULATES,Chemoresistance,Acute Myeloid Leukemia
206,Genistein Ameliorates Renal Fibrosis Through Regulation Snail via m6A RNA Demethylase ALKBH5.,Genistein,TREATS,Renal Fibrosis,Renal Fibrosis
206,Genistein Ameliorates Renal Fibrosis Through Regulation Snail via m6A RNA Demethylase ALKBH5.,Genistein,AFFECTS,ALKBH5,Renal Fibrosis
206,Genistein Ameliorates Renal Fibrosis Through Regulation Snail via m6A RNA Demethylase ALKBH5.,ALKBH5,AFFECTS,Snail,Renal Fibrosis
206,Genistein Ameliorates Renal Fibrosis Through Regulation Snail via m6A RNA Demethylase ALKBH5.,Snail,TREATS,Renal Fibrosis,Renal Fibrosis
152,Dexmedetomidine Suppressed the Biological Behavior of HK-2 Cells Treated with LPS by Down-Regulating ALKBH5.,Dexmedetomidine,INHIBITS,ALKBH5,HK-2 Cells
152,Dexmedetomidine Suppressed the Biological Behavior of HK-2 Cells Treated with LPS by Down-Regulating ALKBH5.,Dexmedetomidine,INHIBITS,Biological Behavior of HK-2 Cells Treated with LPS,HK-2 Cells
152,Dexmedetomidine Suppressed the Biological Behavior of HK-2 Cells Treated with LPS by Down-Regulating ALKBH5.,ALKBH5,INHIBITS,Biological Behavior of HK-2 Cells Treated with LPS,HK-2 Cells
237,HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.,HIF-1alpha,CAUSES,YTHDF1,Hepatocellular Carcinoma
237,HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.,Hypoxia,CAUSES,autophagy,Hepatocellular Carcinoma
237,HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.,YTHDF1,STIMULATES,autophagy,Hepatocellular Carcinoma
237,HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.,YTHDF1,STIMULATES,malignancy,Hepatocellular Carcinoma
237,HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.,YTHDF1,STIMULATES,ATG2A,Hepatocellular Carcinoma
237,HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.,YTHDF1,STIMULATES,ATG14,Hepatocellular Carcinoma
237,HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.,ATG2A,STIMULATES,autophagy,Hepatocellular Carcinoma
237,HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.,ATG14,STIMULATES,autophagy,Hepatocellular Carcinoma
237,HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.,ATG2A,STIMULATES,malignancy,Hepatocellular Carcinoma
237,HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.,ATG14,STIMULATES,malignancy,Hepatocellular Carcinoma
315,Knockdown of METTL3 inhibits enterovirus 71 induced apoptosis of mouse Schwann cell through regulation of autophagy.,dummy,INHIBITS,METTL3,mouse Schwann cells
315,Knockdown of METTL3 inhibits enterovirus 71 induced apoptosis of mouse Schwann cell through regulation of autophagy.,METTL3,INHIBITS,Apoptosis,mouse Schwann cells
315,Knockdown of METTL3 inhibits enterovirus 71 induced apoptosis of mouse Schwann cell through regulation of autophagy.,Enterovirus 71,CAUSES,Apoptosis,mouse Schwann cells
315,Knockdown of METTL3 inhibits enterovirus 71 induced apoptosis of mouse Schwann cell through regulation of autophagy.,METTL3,AFFECTS,Autophagy,mouse Schwann cells
315,Knockdown of METTL3 inhibits enterovirus 71 induced apoptosis of mouse Schwann cell through regulation of autophagy.,Autophagy,AFFECTS,Apoptosis,mouse Schwann cells
148,METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.,METTL3,STIMULATES,Tumorigenesis,Oral Squamous Cell Carcinoma
148,METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.,METTL3,STIMULATES,Metastasis,Oral Squamous Cell Carcinoma
148,METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.,METTL3,CONVERTS_TO,BMI1,Oral Squamous Cell Carcinoma
148,METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.,BMI1,STIMULATES,Tumorigenesis,Oral Squamous Cell Carcinoma
148,METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.,BMI1,STIMULATES,Metastasis,Oral Squamous Cell Carcinoma
57,RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.,FTO,STIMULATES,Progression,Breast Tumor
57,RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.,FTO,INHIBITS,BNIP3,Breast Tumor
57,RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.,BNIP3,INHIBITS,Progression,Breast Tumor
70,The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of CYR61 mRNA.,ALKBH5,AFFECTS,Trophoblast Invasion,Maternal-Fetal Interface
70,The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of CYR61 mRNA.,ALKBH5,AFFECTS,CYR61,Maternal-Fetal Interface
70,The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of CYR61 mRNA.,CYR61,AFFECTS,Trophoblast Invasion,Maternal-Fetal Interface
132,Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8.,METTL3,INHIBITS,pyroptosis,High-glucose induced RPE cell
132,Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8.,METTL3,AFFECTS,DGCR8,High-glucose induced RPE cell
132,Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8.,DGCR8,AFFECTS,miR-25-3p/PTEN/Akt signaling cascade,High-glucose induced RPE cell
132,Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8.,miR-25-3p/PTEN/Akt signaling cascade,AFFECTS,pyroptosis,High-glucose induced RPE cell
272,METTL3 involves the progression of osteoarthritis probably by affecting ECM degradation and regulating the inflammatory response.,METTL3,ASSOCIATED_WITH,Progression,Osteoarthritis
272,METTL3 involves the progression of osteoarthritis probably by affecting ECM degradation and regulating the inflammatory response.,METTL3,AFFECTS,ECM,Osteoarthritis
272,METTL3 involves the progression of osteoarthritis probably by affecting ECM degradation and regulating the inflammatory response.,METTL3,AFFECTS,inflammatory response,Osteoarthritis
272,METTL3 involves the progression of osteoarthritis probably by affecting ECM degradation and regulating the inflammatory response.,Progression,AFFECTS,ECM,Osteoarthritis
272,METTL3 involves the progression of osteoarthritis probably by affecting ECM degradation and regulating the inflammatory response.,Progression,AFFECTS,inflammatory response,Osteoarthritis
107,The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.,YTHDF1,STIMULATES,Progression,Ovarian Cancer
107,The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.,YTHDF1,AUGMENTS,EIF3C,Ovarian Cancer
107,The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.,EIF3C,STIMULATES,Progression,Ovarian Cancer
321,C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1.,C5aR1-positive neutrophils,STIMULATES,glycolysis,Breast Cancer
321,C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1.,C5aR1-positive neutrophils,AFFECTS,WTAP,Breast Cancer
321,C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1.,WTAP,CONVERTS_TO,m6A,Breast Cancer
321,C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1.,m6A,LOCATES,ENO1,Breast Cancer
321,C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1.,ENO1,AFFECTS,glycolysis,Breast Cancer
290,METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer.,METTL16,STIMULATES,Cell Proliferation,Gastric Cancer
290,METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer.,METTL16,STIMULATES,Cyclin D1,Gastric Cancer
290,METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer.,Cyclin D1,STIMULATES,Cell Proliferation,Gastric Cancer
135,METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.,METTL3,STIMULATES,Progression,Nasopharyngeal Carcinoma
135,METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.,METTL3,AFFECTS,M6A,Nasopharyngeal Carcinoma
135,METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.,M6A,LOCATES,EZH2,Nasopharyngeal Carcinoma
135,METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.,EZH2,STIMULATES,Progression,Nasopharyngeal Carcinoma
134,Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.,Simvastatin,AUGMENTS,Progression,Lung Cancer
134,Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.,Simvastatin,CAUSES,METTL3,Lung Cancer
134,Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.,m6A,LOCATES,EZH2,Lung Cancer
134,Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.,METTL3,CAUSES,m6A,Lung Cancer
134,Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA.,EZH2,AUGMENTS,Progression,Lung Cancer
76,METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.,METTL3,INHIBITS,hepatic insulin sensitivity,Hepatic
76,METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.,METTL3,AFFECTS,N6-methyladenosine,Hepatic
76,METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.,N6-methyladenosine,LOCATES,Fasn,Hepatic
76,METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.,METTL3,STIMULATES,Fatty acid metabolism,Hepatic
76,METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.,Fasn,INHIBITS,hepatic insulin sensitivity,Hepatic
76,METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.,Fatty acid metabolism,INHIBITS,hepatic insulin sensitivity,Hepatic
104,DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.,DDX3,AFFECTS,cisplatin resistance,OSCC
104,DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.,DDX3,AFFECTS,ALKBH5,OSCC
104,DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.,ALKBH5,CONVERTS_TO,m6A,OSCC
104,DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.,m6A,LOCATES,FOXM1,OSCC
104,DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.,m6A,LOCATES,NANOG,OSCC
104,DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.,NANOG,AFFECTS,cisplatin resistance,OSCC
104,DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG.,FOXM1,AFFECTS,cisplatin resistance,OSCC
216,ALKBH5-mediated m6A demethylation of FOXM1 mRNA promotes progression of uveal melanoma.,ALKBH5,CONVERTS_TO,m6A,Uveal Melanoma
216,ALKBH5-mediated m6A demethylation of FOXM1 mRNA promotes progression of uveal melanoma.,m6A,LOCATES,FOXM1,Uveal Melanoma
216,ALKBH5-mediated m6A demethylation of FOXM1 mRNA promotes progression of uveal melanoma.,FOXM1,STIMULATES,Progression,Uveal Melanoma
176,Increased m6A modification of RNA methylation related to the inhibition of demethylase FTO contributes to MEHP-induced Leydig cell injury .,m6A,INHIBITS,FTO,Leydig cell
176,Increased m6A modification of RNA methylation related to the inhibition of demethylase FTO contributes to MEHP-induced Leydig cell injury .,FTO,AFFECTS,injury,Leydig cell
176,Increased m6A modification of RNA methylation related to the inhibition of demethylase FTO contributes to MEHP-induced Leydig cell injury .,MEHP,CAUSES,injury,Leydig cell
318,ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD.,ALKBH5,STIMULATES,Proliferation,Glioma Cells
318,ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD.,ALKBH5,MAINTAINS,G6PD,Glioma Cells
318,ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD.,G6PD,STIMULATES,Proliferation,Glioma Cells
154,N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons.,FTO,AFFECTS,Neuropathic Pain,Primary Sensory Neurons
154,N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons.,FTO,MAINTAINS,G9a Expression,Primary Sensory Neurons
154,N6-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons.,G9a Expression,AFFECTS,Neuropathic Pain,Primary Sensory Neurons
200,"The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.",METTL14,INHIBITS,Proliferation,Gastric Cancer
200,"The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.",METTL14,INHIBITS,Migration,Gastric Cancer
200,"The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.",METTL14,INHIBITS,Invasion,Gastric Cancer
200,"The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.",METTL14,AFFECTS,PI3K/AKT/mTOR signaling pathway,Gastric Cancer
200,"The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.",PI3K/AKT/mTOR signaling pathway,INHIBITS,Proliferation,Gastric Cancer
200,"The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.",PI3K/AKT/mTOR signaling pathway,INHIBITS,Migration,Gastric Cancer
200,"The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.",PI3K/AKT/mTOR signaling pathway,INHIBITS,Invasion,Gastric Cancer
188,YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis.,YTHDF3,CAUSES,m6A-Enriched Gene Transcripts,Breast Cancer
188,YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis.,m6A-Enriched Gene Transcripts,STIMULATES,Brain Metastasis,Breast Cancer
199,HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1alpha.,HBXIP,STIMULATES,Metabolic Reprogramming,Hepatocellular Carcinoma cells
199,HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1alpha.,HBXIP,AFFECTS,METTL3,Hepatocellular Carcinoma cells
199,HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1alpha.,METTL3,AFFECTS,m6A,Hepatocellular Carcinoma cells
199,HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1alpha.,m6A,LOCATES,HIF-1alpha,Hepatocellular Carcinoma cells
199,HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1alpha.,HIF-1alpha,STIMULATES,Metabolic Reprogramming,Hepatocellular Carcinoma cells
186,FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signaling pathway.,FTO,STIMULATES,Metastasis,Endometrial Cancer
186,FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signaling pathway.,FTO,CONVERTS_TO,m6A,Endometrial Cancer
186,FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signaling pathway.,m6A,LOCATES,HOXB13,Endometrial Cancer
186,FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signaling pathway.,FTO,STIMULATES,WNT signaling pathway,Endometrial Cancer
186,FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signaling pathway.,HOXB13,AFFECTS,Metastasis,Endometrial Cancer
186,FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signaling pathway.,WNT signaling pathway,AFFECTS,Metastasis,Endometrial Cancer
169,ALKBH5 regulates IGF1R expression to promote the Proliferation and Tumorigenicity of Endometrial Cancer.,ALKBH5,AFFECTS,IGF1R,Endometrial Cancer
169,ALKBH5 regulates IGF1R expression to promote the Proliferation and Tumorigenicity of Endometrial Cancer.,IGF1R,STIMULATES,Proliferation,Endometrial Cancer
169,ALKBH5 regulates IGF1R expression to promote the Proliferation and Tumorigenicity of Endometrial Cancer.,IGF1R,STIMULATES,Tumorigenicity,Endometrial Cancer
239,RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.,RBM15,STIMULATES,Progression,Laryngeal Squamous Cell Carcinoma
239,RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.,RBM15,AFFECTS,IGF2BP3,Laryngeal Squamous Cell Carcinoma
239,RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.,IGF2BP3,AFFECTS,TMBIM6,Laryngeal Squamous Cell Carcinoma
239,RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.,TMBIM6,STIMULATES,Progression,Laryngeal Squamous Cell Carcinoma
342,Degradation of WTAP blocks antiviral responses by reducing the m6A levels of IRF3 and IFNAR1 mRNA.,dummy,CONVERTS_TO,WTAP,Null
342,Degradation of WTAP blocks antiviral responses by reducing the m6A levels of IRF3 and IFNAR1 mRNA.,WTAP,INHIBITS,antiviral responses,Null
342,Degradation of WTAP blocks antiviral responses by reducing the m6A levels of IRF3 and IFNAR1 mRNA.,WTAP,INHIBITS,IRF3,Null
342,Degradation of WTAP blocks antiviral responses by reducing the m6A levels of IRF3 and IFNAR1 mRNA.,WTAP,INHIBITS,IFNAR1,Null
342,Degradation of WTAP blocks antiviral responses by reducing the m6A levels of IRF3 and IFNAR1 mRNA.,IRF3,INHIBITS,antiviral responses,Null
342,Degradation of WTAP blocks antiviral responses by reducing the m6A levels of IRF3 and IFNAR1 mRNA.,IFNAR1,INHIBITS,antiviral responses,Null
295,YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m6A.,YTHDF2,INHIBITS,Tumorigenicity,Endometrial Cancer
295,YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m6A.,YTHDF2,INHIBITS,IRS1,Endometrial Cancer
295,YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m6A.,m6A,CONVERTS_TO,IRS1,Endometrial Cancer
295,YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m6A.,IRS1,STIMULATES,Tumorigenicity,Endometrial Cancer
314,N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1.,FTO,STIMULATES,Metastasis,Gastric Cancer
314,N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1.,FTO,INHIBITS,m6A,Gastric Cancer
314,N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1.,m6A,LOCATES,ITGB1,Gastric Cancer
314,N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1.,ITGB1,STIMULATES,Metastasis,Gastric Cancer
105,The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.,METTL3,AFFECTS,JUNB,Lung Cancer Cells
105,The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.,METTL3,AFFECTS,Epithelial-Mesenchymal Transition,Lung Cancer Cells
105,The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.,Transforming Growth Factor-beta,CAUSES,Epithelial-Mesenchymal Transition,Lung Cancer Cells
105,The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.,JUNB,AFFECTS,Epithelial-Mesenchymal Transition,Lung Cancer Cells
365,METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway.,METTL3,AFFECTS,M6A,Colistin-induced nephrotoxicity
365,METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway.,M6A,PROCESS_OF,nephrotoxicity,Colistin-induced nephrotoxicity
365,METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway.,colistin,CAUSES,nephrotoxicity,Colistin-induced nephrotoxicity
365,METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway.,M6A,AFFECTS,Keap1/Nrf2 signaling pathway,Colistin-induced nephrotoxicity
365,METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway.,Keap1/Nrf2 signaling pathway,AFFECTS,apoptosis,Colistin-induced nephrotoxicity
365,METTL3-mediated M6A methylation modification is involved in colistin-induced nephrotoxicity through apoptosis mediated by Keap1/Nrf2 signaling pathway.,apoptosis,PROCESS_OF,colistin-induced nephrotoxicity,Colistin-induced nephrotoxicity
251,METTL3-mediated m6A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2.,METTL3,AFFECTS,m6A,Gastric Cancer
251,METTL3-mediated m6A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2.,m6A,LOCATES,SPHK2,Gastric Cancer
251,METTL3-mediated m6A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2.,SPHK2,STIMULATES,Progression,Gastric Cancer
251,METTL3-mediated m6A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2.,SPHK2,INTERACTS_WITH,KLF2,Gastric Cancer
251,METTL3-mediated m6A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2.,KLF2,STIMULATES,Progression,Gastric Cancer
202,Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5.,FTO,STIMULATES,Aortic Dissecting Aneurysms,Vascular Smooth Muscle
202,Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5.,FTO,AFFECTS,m6A,Vascular Smooth Muscle
202,Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5.,m6A,LOCATES,Klf5,Vascular Smooth Muscle
202,Vascular Smooth Muscle FTO Promotes Aortic Dissecting Aneurysms via m6A Modification of Klf5.,Klf5,STIMULATES,Aortic Dissecting Aneurysms,Vascular Smooth Muscle
69,The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.,METTL3,STIMULATES,Progression,Osteosarcoma
69,The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.,METTL3,AFFECTS,m6A,Osteosarcoma
69,The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.,m6A,LOCATES,LEF1,Osteosarcoma
69,The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.,m6A,AFFECTS,Progression,Osteosarcoma
170,ALKBH5 promotes colon cancer progression by decreasing methylation of the lncRNA NEAT1.,ALKBH5,STIMULATES,Progression,Colon Cancer
170,ALKBH5 promotes colon cancer progression by decreasing methylation of the lncRNA NEAT1.,ALKBH5,INHIBITS,NEAT1,Colon Cancer
170,ALKBH5 promotes colon cancer progression by decreasing methylation of the lncRNA NEAT1.,NEAT1,STIMULATES,Osteosarcoma Progression,Colon Cancer
224,"The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.",Hepatic Microenvironment,STIMULATES,Proliferation,Lung Adenocarcinoma cell
224,"The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.",Hepatic Microenvironment,STIMULATES,Metastasis,Lung Adenocarcinoma cell
224,"The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.",Hepatic Microenvironment,STIMULATES,Epithelial-Mesenchymal Transition,Lung Adenocarcinoma cell
224,"The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.",Hepatic Microenvironment,AFFECTS,METTL3,Lung Adenocarcinoma cell
224,"The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.",METTL3,AFFECTS,N6-methyladenosine,Lung Adenocarcinoma cell
224,"The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.",N6-methyladenosine,LOCATES,YAP1,Lung Adenocarcinoma cell
224,"The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.",YAP1,STIMULATES,Proliferation,Lung Adenocarcinoma cell
224,"The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.",YAP1,STIMULATES,Metastasis,Lung Adenocarcinoma cell
224,"The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1.",YAP1,STIMULATES,Epithelial-Mesenchymal Transition,Lung Adenocarcinoma cell
45,Loss of m6A on FAM134B promotes adipogenesis in porcine adipocytes through m6A-YTHDF2-dependent way.,dummy,INHIBITS,m6A,Porcine Adipocytes
45,Loss of m6A on FAM134B promotes adipogenesis in porcine adipocytes through m6A-YTHDF2-dependent way.,m6A,LOCATES,FAM134B,Porcine Adipocytes
45,Loss of m6A on FAM134B promotes adipogenesis in porcine adipocytes through m6A-YTHDF2-dependent way.,FAM134B,STIMULATES,Adipogenesis,Porcine Adipocytes
45,Loss of m6A on FAM134B promotes adipogenesis in porcine adipocytes through m6A-YTHDF2-dependent way.,FAM134B,AFFECTS,m6a,Porcine Adipocytes
45,Loss of m6A on FAM134B promotes adipogenesis in porcine adipocytes through m6A-YTHDF2-dependent way.,YTHDF2,INTERACTS_WITH,m6a,Porcine Adipocytes
45,Loss of m6A on FAM134B promotes adipogenesis in porcine adipocytes through m6A-YTHDF2-dependent way.,m6a,STIMULATES,Adipogenesis,Porcine Adipocytes
163,WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m6A-dependent manner.,WTAP,STIMULATES,tumorigenesis,Osteosarcoma
163,WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m6A-dependent manner.,WTAP,AFFECTS,m6A,Osteosarcoma
163,WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m6A-dependent manner.,m6A,INHIBITS,HMBOX1,Osteosarcoma
163,WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m6A-dependent manner.,HMBOX1,STIMULATES,tumorigenesis,Osteosarcoma
218,ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma.,ALKBH5,INHIBITS,Tumor Progression,Osteosarcoma
218,ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma.,ALKBH5,AFFECTS,m6A,Osteosarcoma
218,ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma.,m6A,INHIBITS,pre-miR-181b-1/YAP signaling axis,Osteosarcoma
218,ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma.,pre-miR-181b-1/YAP signaling axis,INHIBITS,Tumor Progression,Osteosarcoma
357,Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification.,Mettl3,INHIBITS,Apoptosis,chondrocytes in Inflammation
357,Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification.,Mettl3,INHIBITS,Autophagy,chondrocytes in Inflammation
357,Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification.,Mettl3,AFFECTS,m6A,chondrocytes in Inflammation
357,Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification.,Ythdf1,INTERACTS_WITH,m6A,chondrocytes in Inflammation
357,Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification.,m6A,AFFECTS,Bcl2 stability,chondrocytes in Inflammation
357,Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification.,Bcl2 stability,INHIBITS,Apoptosis,chondrocytes in Inflammation
357,Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification.,Bcl2 stability,INHIBITS,Autophagy,chondrocytes in Inflammation
329,YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation.,YTHDF1,STIMULATES,Cyclin B1 Translation,Lung Adenocarcinoma with KRAS/TP53 Co-Mutation
329,YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation.,YTHDF1,AFFECTS,Poor prognosis,Lung Adenocarcinoma with KRAS/TP53 Co-Mutation
329,YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation.,YTHDF1,INTERACTS_WITH,m6A,Lung Adenocarcinoma with KRAS/TP53 Co-Mutation
329,YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation.,m6A,STIMULATES,Cyclin B1 Translation,Lung Adenocarcinoma with KRAS/TP53 Co-Mutation
106,Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.,Total Panax notoginseng saponin,INHIBITS,Proliferation,Vascular smooth muscle cell
106,Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.,Total Panax notoginseng saponin,INHIBITS,Migration,Vascular smooth muscle cell
106,Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.,Total Panax notoginseng saponin,INHIBITS,Intimal hyperplasia,Vascular smooth muscle cell
106,Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.,m6A,AFFECTS,WTAP/p16 signals,Vascular smooth muscle cell
106,Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.,Total Panax notoginseng saponin,AFFECTS,m6A,Vascular smooth muscle cell
106,Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.,WTAP/p16 signals,INHIBITS,Proliferation,Vascular smooth muscle cell
106,Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.,WTAP/p16 signals,INHIBITS,Migration,Vascular smooth muscle cell
106,Total Panax notoginseng saponin inhibits vascular smooth muscle cell proliferation and migration and intimal hyperplasia by regulating WTAP/p16 signals via m6A modulation.,WTAP/p16 signals,INHIBITS,Intimal hyperplasia,Vascular smooth muscle cell
133,YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.,YTHDF2,STIMULATES,stem cell Phenotype,Liver Cancer
133,YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.,YTHDF2,STIMULATES,Cancer Metastasis,Liver Cancer
133,YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.,m6A,AFFECTS,OCT4 Expression,Liver Cancer
133,YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.,YTHDF2,INTERACTS_WITH,m6A RNA methylation,Liver Cancer
133,YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.,OCT4 Expression,STIMULATES,stem cell Phenotype,Liver Cancer
133,YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.,OCT4 Expression,STIMULATES,Cancer Metastasis,Liver Cancer
15,Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline.,3' 5' RNA Helicase YTHDC2,AFFECTS,m6A Transcripts,Mammalian Germline
15,Regulation of m6A Transcripts by the 3' 5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline.,m6A Transcripts,CAUSES,Meiotic Program,Mammalian Germline
123,METTL3 enhances cell adhesion through stabilizing integrin _1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma.,METTL3,AUGMENTS,Cell Adhesion,Prostatic Carcinoma
123,METTL3 enhances cell adhesion through stabilizing integrin _1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma.,METTL3,AFFECTS,m6A,Prostatic Carcinoma
123,METTL3 enhances cell adhesion through stabilizing integrin _1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma.,HuR,INTERACTS_WITH,m6A,Prostatic Carcinoma
123,METTL3 enhances cell adhesion through stabilizing integrin _1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma.,m6A,MAINTAINS,integrin _1 mRNA,Prostatic Carcinoma
123,METTL3 enhances cell adhesion through stabilizing integrin _1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma.,integrin _1 mRNA,AUGMENTS,Cell Adhesion,Prostatic Carcinoma
41,MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m6A-YTHDF1-dependent mechanism.,MTCH2,STIMULATES,adipogenesis,intramuscular preadipocyte
41,MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m6A-YTHDF1-dependent mechanism.,MTCH2,AFFECTS,m6A,intramuscular preadipocyte
41,MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m6A-YTHDF1-dependent mechanism.,YTHDF1,INTERACTS_WITH,m6A,intramuscular preadipocyte
41,MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m6A-YTHDF1-dependent mechanism.,m6A,STIMULATES,adipogenesis,intramuscular preadipocyte
241,FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner.,FTO,AFFECTS,myoblast proliferation,Null
241,FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner.,FTO,AFFECTS,m6A,Null
241,FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner.,m6A,AFFECTS,CCND1 expression,Null
241,FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner.,YTHDF2,INTERACTS_WITH,m6A,Null
241,FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner.,CCND1 expression,AFFECTS,myoblast proliferation,Null
40,FTO regulates adipogenesis by controlling cell cycle progression via m6A-YTHDF2 dependent mechanism.,FTO,AFFECTS,Adipogenesis,Adipogenesis/Adipocytes
40,FTO regulates adipogenesis by controlling cell cycle progression via m6A-YTHDF2 dependent mechanism.,FTO,AFFECTS,m6A,Adipogenesis/Adipocytes
40,FTO regulates adipogenesis by controlling cell cycle progression via m6A-YTHDF2 dependent mechanism.,m6A,AFFECTS,Cell cycle progression,Adipogenesis/Adipocytes
40,FTO regulates adipogenesis by controlling cell cycle progression via m6A-YTHDF2 dependent mechanism.,YTHDF2,INTERACTS_WITH,m6A,Adipogenesis/Adipocytes
40,FTO regulates adipogenesis by controlling cell cycle progression via m6A-YTHDF2 dependent mechanism.,cell cycle progression,AFFECTS,Adipogenesis,Adipogenesis/Adipocytes
53,METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPbeta pathway via an m6A-YTHDF2-dependent manner.,METTL3,INHIBITS,differentiation,BMSC adipogenic
53,METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPbeta pathway via an m6A-YTHDF2-dependent manner.,METTL3,AFFECTS,m6A,BMSC adipogenic
53,METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPbeta pathway via an m6A-YTHDF2-dependent manner.,m6A,INTERACTS_WITH,JAK1/STAT5/C/EBPbeta pathway,BMSC adipogenic
53,METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPbeta pathway via an m6A-YTHDF2-dependent manner.,YTHDF2,INTERACTS_WITH,m6A,BMSC adipogenic
53,METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPbeta pathway via an m6A-YTHDF2-dependent manner.,JAK1/STAT5/C/EBPbeta pathway,INHIBITS,differentiation,BMSC adipogenic
223,METTL3 restrains papillary thyroid cancer progression via m6A/c-Rel/IL-8 mediated neutrophils infiltration.,METTL3,INHIBITS,Progression,Papillary Thyroid Cancer
223,METTL3 restrains papillary thyroid cancer progression via m6A/c-Rel/IL-8 mediated neutrophils infiltration.,METTL3,AFFECTS,m6A/c-Rel/IL-8,Papillary Thyroid Cancer
223,METTL3 restrains papillary thyroid cancer progression via m6A/c-Rel/IL-8 mediated neutrophils infiltration.,m6A/c-Rel/IL-8,AFFECTS,Neutrophils Infiltration,Papillary Thyroid Cancer
223,METTL3 restrains papillary thyroid cancer progression via m6A/c-Rel/IL-8 mediated neutrophils infiltration.,m6A/c-Rel/IL-8,INHIBITS,Progression,Papillary Thyroid Cancer
103,YTHDF2 promotes spermagonial adhesion through modulating MMPs decay via m6A/mRNA pathway.,YTHDF2,STIMULATES,spermagonial adhesion,Null
103,YTHDF2 promotes spermagonial adhesion through modulating MMPs decay via m6A/mRNA pathway.,YTHDF2,AFFECTS,m6A/mRNA pathway,Null
103,YTHDF2 promotes spermagonial adhesion through modulating MMPs decay via m6A/mRNA pathway.,m6A/mRNA pathway,AFFECTS,MMPs decay,Null
103,YTHDF2 promotes spermagonial adhesion through modulating MMPs decay via m6A/mRNA pathway.,MMPs decay,STIMULATES,spermagonial adhesion,Null
98,m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.,m6A mRNA methylation,STIMULATES,YAP translation,NSCLC
98,m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.,m6A mRNA methylation,AUGMENTS,YAP activity,NSCLC
98,m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.,m6A mRNA methylation,AFFECTS,MALAT1-miR-1914-3p-YAP axis,NSCLC
98,m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.,METTL3,CAUSES,m6A mRNA methylation,NSCLC
98,m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.,MALAT1-miR-1914-3p-YAP axis,CAUSES,Drug resistance,NSCLC
98,m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.,MALAT1-miR-1914-3p-YAP axis,CAUSES,Metastasis,NSCLC
98,m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.,Drug resistance,CAUSES,YAP translation,NSCLC
98,m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.,Metastasis,CAUSES,YAP translation,NSCLC
98,m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.,Drug resistance,CAUSES,YAP activity,NSCLC
98,m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.,Metastasis,CAUSES,YAP activity,NSCLC
297,MeCP2 promotes colorectal cancer metastasis by regulating m6A methylation via METTL14.,MeCP2,STIMULATES,Metastasis,Colorectal Cancer
297,MeCP2 promotes colorectal cancer metastasis by regulating m6A methylation via METTL14.,MeCP2,AFFECTS,METTL14,Colorectal Cancer
297,MeCP2 promotes colorectal cancer metastasis by regulating m6A methylation via METTL14.,METTL14,AFFECTS,m6A methylation,Colorectal Cancer
297,MeCP2 promotes colorectal cancer metastasis by regulating m6A methylation via METTL14.,m6A methylation,STIMULATES,Metastasis,Colorectal Cancer
146,LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression.,LNC942,STIMULATES,METTL14,Breast Cancer cell
146,LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression.,METTL14,AFFECTS,m6A methylation,Breast Cancer cell
146,LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression.,m6A methylation,STIMULATES,Proliferation,Breast Cancer cell
146,LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression.,m6A methylation,STIMULATES,Progression,Breast Cancer cell
247,MiR-4729 regulates TIE1 mRNA m6A modification and angiogenesis in hemorrhoids by targeting METTL14.,MiR-4729,AFFECTS,TIE1 mRNA m6A modification,Hemorrhoids
247,MiR-4729 regulates TIE1 mRNA m6A modification and angiogenesis in hemorrhoids by targeting METTL14.,MiR-4729,AFFECTS,Angiogenesis,Hemorrhoids
247,MiR-4729 regulates TIE1 mRNA m6A modification and angiogenesis in hemorrhoids by targeting METTL14.,MiR-4729,INTERACTS_WITH,METTL14,Hemorrhoids
247,MiR-4729 regulates TIE1 mRNA m6A modification and angiogenesis in hemorrhoids by targeting METTL14.,METTL14,AFFECTS,TIE1 mRNA m6A modification,Hemorrhoids
247,MiR-4729 regulates TIE1 mRNA m6A modification and angiogenesis in hemorrhoids by targeting METTL14.,METTL14,AFFECTS,Angiogenesis,Hemorrhoids
276,Novel circGFRalpha1 Promotes Self-Renewal of Female Germline Stem Cells Mediated by m6A Writer METTL14.,circGFRalpha1,STIMULATES,Self-Renewal,Female Germline Stem Cells
276,Novel circGFRalpha1 Promotes Self-Renewal of Female Germline Stem Cells Mediated by m6A Writer METTL14.,circGFRalpha1,AFFECTS,METTL14,Female Germline Stem Cells
276,Novel circGFRalpha1 Promotes Self-Renewal of Female Germline Stem Cells Mediated by m6A Writer METTL14.,METTL14,AFFECTS,Self-Renewal,Female Germline Stem Cells
265,CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.,CLK1/SRSF5 pathway,CAUSES,aberrant exon skipping,Pancreatic Cancer
265,CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.,aberrant exon skipping,LOCATES,Cyclin L2,Pancreatic Cancer
265,CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.,aberrant exon skipping,LOCATES,METTL14,Pancreatic Cancer
265,CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.,CLK1/SRSF5 pathway,STIMULATES,Growth,Pancreatic Cancer
265,CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.,CLK1/SRSF5 pathway,STIMULATES,Metastasis,Pancreatic Cancer
316,miR-302a-3p suppresses melanoma cell progression via targeting METTL3.,miR-302a-3p,INHIBITS,Progression,Melanoma Cell
316,miR-302a-3p suppresses melanoma cell progression via targeting METTL3.,miR-302a-3p,INTERACTS_WITH,METTL3,Melanoma Cell
316,miR-302a-3p suppresses melanoma cell progression via targeting METTL3.,METTL3,INHIBITS,Progression,Melanoma Cell
77,ZFP217 regulates adipogenesis by controlling mitotic clonal expansion in a METTL3-m6A dependent manner.,ZFP217,AFFECTS,adipogenesis,Null
77,ZFP217 regulates adipogenesis by controlling mitotic clonal expansion in a METTL3-m6A dependent manner.,ZFP217,AFFECTS,METTL3,Null
77,ZFP217 regulates adipogenesis by controlling mitotic clonal expansion in a METTL3-m6A dependent manner.,METTL3,AFFECTS,m6A,Null
77,ZFP217 regulates adipogenesis by controlling mitotic clonal expansion in a METTL3-m6A dependent manner.,m6A,AFFECTS,mitotic clonal expansion,Null
77,ZFP217 regulates adipogenesis by controlling mitotic clonal expansion in a METTL3-m6A dependent manner.,mitotic clonal expansion,AFFECTS,adipogenesis,Null
204,miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer.,miR-338-5p,INHIBITS,Cell Growth,Lung Cancer
204,miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer.,miR-338-5p,INHIBITS,Migration,Lung Cancer
204,miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer.,miR-338-5p,INHIBITS,METTL3/m6A/c-Myc pathway,Lung Cancer
204,miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer.,METTL3/m6A/c-Myc pathway,AFFECTS,Cell Growth,Lung Cancer
204,miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer.,METTL3/m6A/c-Myc pathway,AFFECTS,Migration,Lung Cancer
229,FTO overexpression inhibits apoptosis of hypoxia/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt.,FTO overexpression,INHIBITS,Apoptosis,Hypoxia/reoxygenation-treated myocardial cells
229,FTO overexpression inhibits apoptosis of hypoxia/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt.,FTO,AFFECTS,m6A,Hypoxia/reoxygenation-treated myocardial cells
229,FTO overexpression inhibits apoptosis of hypoxia/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt.,m6A,LOCATES,Mhrt,Hypoxia/reoxygenation-treated myocardial cells
229,FTO overexpression inhibits apoptosis of hypoxia/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt.,Mhrt,INHIBITS,Apoptosis,Hypoxia/reoxygenation-treated myocardial cells
185,METTL3 promotes IL-1beta-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p.,METTL3,STIMULATES,Degeneration,endplate chondrocytes
185,METTL3 promotes IL-1beta-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p.,METTL3,STIMULATES,m6A,endplate chondrocytes
185,METTL3 promotes IL-1beta-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p.,m6A,LOCATES,miR-126-5p,endplate chondrocytes
185,METTL3 promotes IL-1beta-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p.,IL-1beta,CAUSES,Degeneration,endplate chondrocytes
185,METTL3 promotes IL-1beta-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p.,m6A,STIMULATES,Degeneration,endplate chondrocytes
364,Methyltransferase-like 3 (METTL3) attenuates cardiomyocyte apoptosis with myocardial ischemia-reperfusion (I/R) injury through miR-25-3p and miR-873-5p.,METTL3,INHIBITS,Cardiomyocyte apoptosis,Myocardial ischemia-reperfusion (I/R) injury
364,Methyltransferase-like 3 (METTL3) attenuates cardiomyocyte apoptosis with myocardial ischemia-reperfusion (I/R) injury through miR-25-3p and miR-873-5p.,METTL3,AFFECTS,miR-25-3p,Myocardial ischemia-reperfusion (I/R) injury
364,Methyltransferase-like 3 (METTL3) attenuates cardiomyocyte apoptosis with myocardial ischemia-reperfusion (I/R) injury through miR-25-3p and miR-873-5p.,METTL3,AFFECTS,miR-873-5p,Myocardial ischemia-reperfusion (I/R) injury
364,Methyltransferase-like 3 (METTL3) attenuates cardiomyocyte apoptosis with myocardial ischemia-reperfusion (I/R) injury through miR-25-3p and miR-873-5p.,miR-25-3p,INHIBITS,Cardiomyocyte apoptosis,Myocardial ischemia-reperfusion (I/R) injury
364,Methyltransferase-like 3 (METTL3) attenuates cardiomyocyte apoptosis with myocardial ischemia-reperfusion (I/R) injury through miR-25-3p and miR-873-5p.,miR-873-5p,INHIBITS,Cardiomyocyte apoptosis,Myocardial ischemia-reperfusion (I/R) injury
179,METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA.,METTL3,PREVENTS,Premature aging,Premature aging
179,METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA.,METTL3,AFFECTS,m6A,Premature aging
179,METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA.,m6A,MAINTAINS,MIS12,Premature aging
179,METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA.,MIS12,AFFECTS,Premature aging,Premature aging
27,METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.,METTL3,AFFECTS,alternative splicing of MyD88,Human dental pulp cells
27,METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.,lipopolysaccharide,CAUSES,inflammatory response,Human dental pulp cells
27,METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.,METTL3,AFFECTS,inflammatory response,Human dental pulp cells
27,METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.,inflammatory response,AFFECTS,alternative splicing of MyD88,Human dental pulp cells
88,TNF-alpha suppresses sweat gland differentiation of MSCs by reducing FTO-mediated m6A-demethylation of Nanog mRNA.,TNF-alpha,INHIBITS,Sweat gland differentiation,MSCs
88,TNF-alpha suppresses sweat gland differentiation of MSCs by reducing FTO-mediated m6A-demethylation of Nanog mRNA.,TNF-alpha,INHIBITS,FTO,MSCs
88,TNF-alpha suppresses sweat gland differentiation of MSCs by reducing FTO-mediated m6A-demethylation of Nanog mRNA.,FTO,AFFECTS,m6A-demethylation,MSCs
88,TNF-alpha suppresses sweat gland differentiation of MSCs by reducing FTO-mediated m6A-demethylation of Nanog mRNA.,m6A-demethylation,LOCATES,Nanog mRNA,MSCs
88,TNF-alpha suppresses sweat gland differentiation of MSCs by reducing FTO-mediated m6A-demethylation of Nanog mRNA.,m6A-demethylation,AFFECTS,Sweat gland differentiation,MSCs
119,YTHDF2 destabilizes m6A-modified neural-specific RNAs to restrain differentiation in induced pluripotent stem cells.,YTHDF2,DISRUPTS,neural-specific RNAs,Induced pluripotent stem cells
119,YTHDF2 destabilizes m6A-modified neural-specific RNAs to restrain differentiation in induced pluripotent stem cells.,m6A,AFFECTS,neural-specific RNAs,Induced pluripotent stem cells
119,YTHDF2 destabilizes m6A-modified neural-specific RNAs to restrain differentiation in induced pluripotent stem cells.,neural-specific RNAs,INHIBITS,Differentiation,Induced pluripotent stem cells
325,Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.,Total Flavones of Abelmoschus manihot,INTERACTS_WITH,METTL3,High Glucose Conditions
325,Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.,METTL3,AFFECTS,m6a,High Glucose Conditions
325,Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.,m6a,AFFECTS,NLRP3-Inflammasome Activation,High Glucose Conditions
325,Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.,m6a,AFFECTS,PTEN/PI3K/Akt Signaling,High Glucose Conditions
325,Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.,Total Flavones of Abelmoschus manihot,TREATS,Podocyte Pyroptosis,High Glucose Conditions
325,Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.,Total Flavones of Abelmoschus manihot,TREATS,Injury,High Glucose Conditions
325,Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.,NLRP3-Inflammasome Activation,TREATS,Podocyte Pyroptosis,High Glucose Conditions
325,Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.,PTEN/PI3K/Akt Signaling,TREATS,Podocyte Pyroptosis,High Glucose Conditions
325,Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.,NLRP3-Inflammasome Activation,TREATS,Injury,High Glucose Conditions
325,Total Flavones of Abelmoschus manihot Ameliorates Podocyte Pyroptosis and Injury in High Glucose Conditions by Targeting METTL3-Dependent m6A Modification-Mediated NLRP3-Inflammasome Activation and PTEN/PI3K/Akt Signaling.,PTEN/PI3K/Akt Signaling,TREATS,Injury,High Glucose Conditions
274,Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA.,circZbtb20,MAINTAINS,ILC3 homeostasis,Null
274,Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA.,circZbtb20,MAINTAINS,ILC3 function,Null
274,Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA.,circZbtb20,AFFECTS,Alkbh5,Null
274,Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA.,Alkbh5,AFFECTS,m6A demethylation,Null
274,Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA.,m6A demethylation,LOCATES,Nr4a1,Null
274,Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA.,Nr4a1,MAINTAINS,ILC3 homeostasis,Null
274,Circular RNA circZbtb20 maintains ILC3 homeostasis and function via Alkbh5-dependent m6A demethylation of Nr4a1 mRNA.,Nr4a1,MAINTAINS,ILC3 function,Null
181,The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.,METTL3,AFFECTS,DLBCL,DLBCL Development
181,The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.,METTL3,AFFECTS,m6A,DLBCL Development
181,The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.,m6A,LOCATES,PEDF,DLBCL Development
181,The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.,PEDF,AFFECTS,DLBCL,DLBCL Development
331,The m6A methyltransferase METTL3 modifies PGC-1alpha mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes.,METTL3,AFFECTS,PGC-1alpha mRNA,monocytes
331,The m6A methyltransferase METTL3 modifies PGC-1alpha mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes.,PGC-1alpha,STIMULATES,mitochondrial dysfunction,monocytes
331,The m6A methyltransferase METTL3 modifies PGC-1alpha mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes.,PGC-1alpha,STIMULATES,inflammation,monocytes
331,The m6A methyltransferase METTL3 modifies PGC-1alpha mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes.,oxLDL,CAUSES,inflammation,monocytes
256,Role of epigenetic m6A RNA methylation in vascular development: mettl3 regulates vascular development through PHLPP2/mTOR-AKT signaling.,mettl3,AFFECTS,Vascular Development,Vascular Development
256,Role of epigenetic m6A RNA methylation in vascular development: mettl3 regulates vascular development through PHLPP2/mTOR-AKT signaling.,mettl3,AFFECTS,PHLPP2/mTOR-AKT signaling,Vascular Development
256,Role of epigenetic m6A RNA methylation in vascular development: mettl3 regulates vascular development through PHLPP2/mTOR-AKT signaling.,PHLPP2/mTOR-AKT signaling,AFFECTS,Vascular Development,Vascular Development
215,METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner.,METTL3,STIMULATES,Adriamycin resistance,MCF-7 breast cancer cells
215,METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner.,METTL3,AFFECTS,m6a,MCF-7 breast cancer cells
215,METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner.,m6a,STIMULATES,Pri-microRNA-221-3p maturation,MCF-7 breast cancer cells
215,METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner.,Pri-microRNA-221-3p maturation,STIMULATES,Adriamycin resistance,MCF-7 breast cancer cells
65,METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.,METTL3,STIMULATES,Tumor Proliferation,Bladder Cancer
65,METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.,METTL3,AFFECTS,m6a,Bladder Cancer
65,METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.,m6a,STIMULATES,pri-miR221/222 Maturation,Bladder Cancer
65,METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.,pri-miR221/222 Maturation,STIMULATES,Tumor Proliferation,Bladder Cancer
344,METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.,METTL3,STIMULATES,Progress,Oral Squamous Cell Carcinoma
344,METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.,METTL3,AFFECTS,m6A,Oral Squamous Cell Carcinoma
344,METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.,m6A,LOCATES,PRMT5,Oral Squamous Cell Carcinoma
344,METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.,m6A,LOCATES,PD-L1,Oral Squamous Cell Carcinoma
344,METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.,PRMT5,STIMULATES,Progress,Oral Squamous Cell Carcinoma
344,METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.,PD-L1,STIMULATES,Progress,Oral Squamous Cell Carcinoma
214,METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease.,METTL14,AFFECTS,PI3K/Akt signaling pathway,diabetic kidney disease
214,METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease.,METTL14,AFFECTS,PTEN,diabetic kidney disease
214,METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease.,PTEN,AFFECTS,epithelial-mesenchymal transition,diabetic kidney disease
214,METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease.,HDAC5,AFFECTS,epithelial-mesenchymal transition,diabetic kidney disease
214,METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease.,epithelial-mesenchymal transition,AFFECTS,PI3K/Akt signaling pathway,diabetic kidney disease
214,METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease.,epithelial-mesenchymal transition,OCCURS_IN,renal tubular cells,diabetic kidney disease
172,METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.,METTL3,AFFECTS,miR-126-5p,Ovarian Cancer
172,METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.,miR-126-5p,STIMULATES,progression,Ovarian Cancer
172,METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.,miR-126-5p,AFFECTS,PTEN,Ovarian Cancer
172,METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.,PTEN,AFFECTS,PI3K/Akt/mTOR pathway,Ovarian Cancer
172,METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.,PI3K/Akt/mTOR pathway,STIMULATES,Progression,Ovarian Cancer
260,YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2.,YTHDF1,COMPLICATES,Progression,Cervical Cancer
260,YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2.,YTHDF1,AFFECTS,m6A,Cervical Cancer
260,YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2.,m6A,STIMULATES,RANBP2,Cervical Cancer
260,YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2.,RANBP2,COMPLICATES,Progression,Cervical Cancer
59,RBM15 Modulates the Function of Chromatin Remodeling Factor BAF155 Through RNA Methylation in Developing Cortex.,RBM15,AFFECTS,BAF155,Developing Cortex
59,RBM15 Modulates the Function of Chromatin Remodeling Factor BAF155 Through RNA Methylation in Developing Cortex.,RBM15,AFFECTS,RNA Methylation,Developing Cortex
59,RBM15 Modulates the Function of Chromatin Remodeling Factor BAF155 Through RNA Methylation in Developing Cortex.,RNA Methylation,AFFECTS,BAF155,Developing Cortex
4,Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.,Hypoxia-inducible factors,AFFECTS,pluripotency factor expression,Breast Cancer cells
4,Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.,Hypoxia-inducible factors,AFFECTS,ZNF217,Breast Cancer cells
4,Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.,Hypoxia-inducible factors,AFFECTS,ALKBH5,Breast Cancer cells
4,Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.,ZNF217,AFFECTS,RNA methylation,Breast Cancer cells
4,Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.,ALKBH5,AFFECTS,RNA methylation,Breast Cancer cells
4,Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.,RNA methylation,AFFECTS,pluripotency factor expression,Breast Cancer cells
385,Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma,Intracellular Fusobacterium nucleatum infection,AUGMENTS,METTL3,esophageal squamous cell carcinoma
385,Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma,METTL3,AFFECTS,m6A methylation,esophageal squamous cell carcinoma
385,Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma,m6A methylation,STIMULATES,metastasis,esophageal squamous cell carcinoma
52,The m6A reader YTHDF1 regulates axon guidance through translational control of Robo3.1 expression.,YTHDF1,AFFECTS,Axon Guidance,Null
52,The m6A reader YTHDF1 regulates axon guidance through translational control of Robo3.1 expression.,YTHDF1,AFFECTS,Robo3.1 expression,Null
52,The m6A reader YTHDF1 regulates axon guidance through translational control of Robo3.1 expression.,Robo3.1 expression,AFFECTS,Axon Guidance,Null
140,The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA.,METTL3,COMPLICATES,Progression,Nasopharyngeal Carcinoma
140,The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA.,METTL3,AFFECTS,m6A,Nasopharyngeal Carcinoma
140,The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA.,m6A,AFFECTS,Snail mRNA,Nasopharyngeal Carcinoma
140,The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA.,Snail mRNA,CAUSES,EMT,Nasopharyngeal Carcinoma
140,The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA.,EMT,COMPLICATES,Progression,Nasopharyngeal Carcinoma
16,RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.,methyltransferase-like 3,STIMULATES,Progression,Liver Cancer
16,RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.,methyltransferase-like 3,AFFECTS,YTHDF2,Liver Cancer
16,RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.,YTHDF2,INHIBITS,SOCS2,Liver Cancer
16,RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.,SOCS2,AFFECTS,Progression,Liver Cancer
155,m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.,METTL3,MAINTAINS,Tumorigenicity,Colon Cancer
155,m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.,METTL3,INHIBITS,SOCS2,Colon Cancer
155,m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.,SOCS2,STIMULATES,Cell Proliferation,Colon Cancer
155,m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.,Cell Proliferation,MAINTAINS,Tumorigenicity,Colon Cancer
74,Acute Deletion of METTL14 in beta-cells of adult mice results in glucose intolerance.,dummy,INHIBITS,METTL14,Beta-cells of adult mice
74,Acute Deletion of METTL14 in beta-cells of adult mice results in glucose intolerance.,METTL14,CAUSES,Glucose intolerance,Beta-cells of adult mice
94,Dynamic effects of Fto in regulating the proliferation and differentiation of adult neural stem cells of mice.,FTO,AFFECTS,Proliferation,Adult neural stem cells of mice
94,Dynamic effects of Fto in regulating the proliferation and differentiation of adult neural stem cells of mice.,FTO,AFFECTS,Differentiation,Adult neural stem cells of mice
99,The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells.,FTO,STIMULATES,Proliferation,Human Cervical Cancer cells
99,The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells.,FTO,STIMULATES,Migration,Human Cervical Cancer cells
136,N6-methyladenosine demethylases Alkbh5/Fto regulate cerebral ischemia-reperfusion injury.,Alkbh5,AFFECTS,Cerebral Ischemia-Reperfusion Injury,cerebral ischemia-reperfusion injury
136,N6-methyladenosine demethylases Alkbh5/Fto regulate cerebral ischemia-reperfusion injury.,Fto,AFFECTS,Cerebral Ischemia-Reperfusion Injury,cerebral ischemia-reperfusion injury
162,The FTO/miR-181b-3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer.,FTO/miR-181b-3p/ARL5B signaling pathway,AFFECTS,Cell migration,Breast Cancer
162,The FTO/miR-181b-3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer.,FTO/miR-181b-3p/ARL5B signaling pathway,AFFECTS,invasion,Breast Cancer
213,m6A-RNA Demethylase FTO Inhibitors Impair Self-Renewal in Glioblastoma Stem Cells.,FTO Inhibitors,INHIBITS,Self-Renewal,Glioblastoma Stem Cells
328,RNA Demethylase FTO Mediated RNA m6A Modification Is Involved in Maintaining Maternal-Fetal Interface in Spontaneous Abortion.,FTO,AFFECTS,RNA m6A Modification,Spontaneous Abortion
328,RNA Demethylase FTO Mediated RNA m6A Modification Is Involved in Maintaining Maternal-Fetal Interface in Spontaneous Abortion.,RNA m6A Modification,MAINTAINS,Maternal-Fetal Interface,Spontaneous Abortion
20,ALKBH5-dependent m6A demethylation controls splicing and stability of long 3'-UTR mRNAs in male germ cells.,ALKBH5,AFFECTS,m6A demethylation,Male germ cells
20,ALKBH5-dependent m6A demethylation controls splicing and stability of long 3'-UTR mRNAs in male germ cells.,m6A demethylation,AFFECTS,Splicing of long 3'-UTR mRNAs,Male germ cells
20,ALKBH5-dependent m6A demethylation controls splicing and stability of long 3'-UTR mRNAs in male germ cells.,m6A demethylation,AFFECTS,Stability of long 3'-UTR mRNAs,Male germ cells
207,The m6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells.,ALKBH5,STIMULATES,Radioresistance,Glioma Stem Cells
207,The m6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells.,ALKBH5,STIMULATES,Invasion Capability,Glioma Stem Cells
289,Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response.,dummy,AFFECTS,ALKBH5,Null
289,Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response.,ALKBH5,AFFECTS,DNA damage response,Null
289,Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response.,ROS,CAUSES,DNA damage response,Null
303,m6A demethylase ALKBH5 controls CD4+ T cell pathogenicity and promotes autoimmunity.,ALKBH5,AFFECTS,pathogenicity,CD4+ T cell
303,m6A demethylase ALKBH5 controls CD4+ T cell pathogenicity and promotes autoimmunity.,ALKBH5,STIMULATES,Autoimmunity,CD4+ T cell
319,M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma.,ALKBH5,AFFECTS,PD-L1,Intrahepatic Cholangiocarcinoma
319,M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma.,ALKBH5,AFFECTS,Tumor Immunoenvironment,Intrahepatic Cholangiocarcinoma
348,m6A demethylase ALKBH5 suppression contributes to esophageal squamous cell carcinoma progression.,ALKBH5 suppression,AFFECTS,Progression,Esophageal Squamous Cell Carcinoma
352,ALKBH5-mediated m6A mRNA methylation governs human embryonic stem cell cardiac commitment.,ALKBH5,AFFECTS,m6A mRNA methylation,Human embryonic stem cell
352,ALKBH5-mediated m6A mRNA methylation governs human embryonic stem cell cardiac commitment.,m6A mRNA methylation,AFFECTS,Cardiac commitment,Human embryonic stem cell
26,Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer.,Oncogene c-Myc,STIMULATES,YTHDF1,Colorectal Cancer
61,YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma.,YTHDF1,AFFECTS,Tumorigenicity,Human Colorectal Carcinoma
61,YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma.,YTHDF1,AFFECTS,Cancer Stem Cell-Like Activity,Human Colorectal Carcinoma
177,m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells.,YTHDF1,INTERACTS_WITH,m6a,cisplatin-resistant ovarian cancer cells
177,m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells.,m6a,AFFECTS,upregulation,cisplatin-resistant ovarian cancer cells
177,m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells.,upregulation,LOCATES,TRIM29,cisplatin-resistant ovarian cancer cells
177,m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells.,TRIM29,STIMULATES,Stem cell-like phenotype,cisplatin-resistant ovarian cancer cells
235,N(6)-methyladenosine-binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay.,YTHDF1,INHIBITS,replication,EBV
235,N(6)-methyladenosine-binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay.,YTHDF1,STIMULATES,RNA decay,EBV
400,The m6A-Binding Protein YTHDF1 Mediates Immune Evasion.,YTHDF1,AFFECTS,Immune Evasion,Null
12,The RNA m6A Reader YTHDF2 Is Essential for the Post-transcriptional Regulation of the Maternal Transcriptome and Oocyte Competence.,YTHDF2,AFFECTS,Maternal Transcriptome,Null
12,The RNA m6A Reader YTHDF2 Is Essential for the Post-transcriptional Regulation of the Maternal Transcriptome and Oocyte Competence.,YTHDF2,AFFECTS,Oocyte Competence,Null
14,Gamete On for m6A: YTHDF2 Exerts Essential Functions in Female Fertility.,YTHDF2,AFFECTS,Essential Functions,Female Fertility
32,Ythdf2-mediated m6A mRNA clearance modulates neural development in mice.,Ythdf2,AFFECTS,m6A mRNA clearance,Neural development in mice
32,Ythdf2-mediated m6A mRNA clearance modulates neural development in mice.,m6A mRNA clearance,AFFECTS,Neural development,Neural development in mice
37,Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion.,dummy,INHIBITS,Ythdf2,hematopoietic stem cell.
37,Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion.,Ythdf2,STIMULATES,expansion,hematopoietic stem cell.
38,Loss of YTHDF2-mediated m6A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration.,dummy,INHIBITS,YTHDF2,Hematopoietic stem cell
38,Loss of YTHDF2-mediated m6A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration.,YTHDF2,INTERACTS_WITH,m6A,Hematopoietic stem cell
38,Loss of YTHDF2-mediated m6A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration.,m6A,STIMULATES,Regeneration,Hematopoietic stem cell
190,The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function.,YTHDF2,INHIBITS,Proinflammatory pathways,Hematopoietic stem cell function
190,The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function.,YTHDF2,MAINTAINS,Hematopoietic stem cell function,Hematopoietic stem cell function
245,N-methyladenosine reader YTHDF2-mediated long noncoding RNA FENDRR degradation promotes cell proliferation in endometrioid endometrial carcinoma.,YTHDF2,AFFECTS,long noncoding RNA FENDRR degradation,Endometrioid Endometrial Carcinoma
245,N-methyladenosine reader YTHDF2-mediated long noncoding RNA FENDRR degradation promotes cell proliferation in endometrioid endometrial carcinoma.,long noncoding RNA FENDRR degradation,STIMULATES,Cell Proliferation,Endometrioid Endometrial Carcinoma
304,The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity.,YTHDF2,AFFECTS,antitumor,NK cell
304,The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity.,YTHDF2,AFFECTS,antiviral Immunity,NK cell
309,PBRM1 Cooperates with YTHDF2 to Control HIF-1alpha Protein Translation.,PBRM1,INTERACTS_WITH,YTHDF2,Null
309,PBRM1 Cooperates with YTHDF2 to Control HIF-1alpha Protein Translation.,PBRM1,AFFECTS,HIF-1alpha Protein Translation,Null
309,PBRM1 Cooperates with YTHDF2 to Control HIF-1alpha Protein Translation.,YTHDF2,AFFECTS,HIF-1alpha Protein Translation,Null
5,Cytoplasmic m6A reader YTHDF3 promotes mRNA translation.,YTHDF3,STIMULATES,mRNA translation,Null
30,Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development.,YTHDC1,AFFECTS,Alternative polyadenylation,mouse oocyte development.
30,Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development.,YTHDC1,AFFECTS,Splicing,mouse oocyte development.
271,Nuclear m6A reader YTHDC1 regulates the scaffold function of LINE1 RNA in mouse ESCs and early embryos.,YTHDC1,AFFECTS,LINE1 RNA,Mouse ESCs and early embryos
313,HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells.,HNRNPA2B1,AFFECTS,Tamoxifen-sensitivity,Breast Cancer cells
313,HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells.,HNRNPA2B1,AFFECTS,Fulvestrant-sensitivity,Breast Cancer cells
313,HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells.,HNRNPA2B1,AFFECTS,endocrine resistance,Breast Cancer cells
46,A novel m6A reader Prrc2a controls oligodendroglial specification and myelination.,Prrc2a,AFFECTS,oligodendroglial specification,Null
46,A novel m6A reader Prrc2a controls oligodendroglial specification and myelination.,Prrc2a,AFFECTS,myelination,Null
183,Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.,dummy,STIMULATES,KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis,Prostate Cancer
183,Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.,KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis,STIMULATES,Progression,Prostate Cancer
60,Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia.,YTHDF2,COMPLICATES,Cancer Stem Cells,Acute Myeloid Leukemia
50,N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling.,METTL3,AFFECTS,Actively Transcribed Genes,Glioma Stem-Like Cells
50,N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling.,METTL3,AFFECTS,Sustenance of the Oncogenic Signaling,Glioma Stem-Like Cells
222,Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.,dummy,DISRUPTS,USP18/FTO/PYCR1 signaling,Bladder Cancer
222,Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.,USP18/FTO/PYCR1 signaling,STIMULATES,Development,Bladder Cancer
222,Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.,USP18/FTO/PYCR1 signaling,STIMULATES,progression,Bladder Cancer
84,The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion.,METTL3,STIMULATES,Proliferation,Pancreatic Cancer
84,The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion.,METTL3,STIMULATES,Invasion,Pancreatic Cancer
102,METTL3-mediated m6A is required for murine oocyte maturation and maternal-to-zygotic transition.,METTL3,AFFECTS,m6A,Murine oocyte
102,METTL3-mediated m6A is required for murine oocyte maturation and maternal-to-zygotic transition.,m6A,CAUSES,maturation,Murine oocyte
102,METTL3-mediated m6A is required for murine oocyte maturation and maternal-to-zygotic transition.,m6A,CAUSES,maternal-to-zygotic transition,Murine oocyte
153,Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells.,Upregulated METTL3,STIMULATES,Cancer Cells,Nasopharyngeal Carcinoma
159,Knockdown of m6A methyltransferase METTL3 in gastric cancer cells results in suppression of cell proliferation.,dummy,INHIBITS,METTL3,Gastric Cancer
159,Knockdown of m6A methyltransferase METTL3 in gastric cancer cells results in suppression of cell proliferation.,METTL3,INHIBITS,Cell Proliferation,Gastric Cancer
182,A defined N6-methyladenosine (m6A) profile conferred by METTL3 regulates muscle stem cell/myoblast state transitions.,METTL3,PRODUCES,N6-methyladenosine (m6A),muscle stem cell/myoblast
182,A defined N6-methyladenosine (m6A) profile conferred by METTL3 regulates muscle stem cell/myoblast state transitions.,N6-methyladenosine (m6A),AFFECTS,state transition,muscle stem cell/myoblast
244,Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis.,dummy,INHIBITS,Mettl3,Bladder Cancer
244,Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis.,Mettl3,INHIBITS,Progression,Bladder Cancer
244,Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis.,Mettl3,INHIBITS,Angiogenesis,Bladder Cancer
263,Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis.,dummy,INHIBITS,Mettl3,Bladder Cancer
263,Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis.,Mettl3,INHIBITS,Progression,Bladder Cancer
263,Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis.,Mettl3,INHIBITS,Angiogenesis,Bladder Cancer
160,The 18S rRNA m6A methyltransferase METTL5 promotes mouse embryonic stem cell differentiation.,METTL5,STIMULATES,differentiation,Mouse embryonic stem cell
3,The Demethylase Activity of FTO (Fat Mass and Obesity Associated Protein) Is Required for Preadipocyte Differentiation.,FTO,CAUSES,Preadipocyte Differentiation,Null
67,m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade.,FTO,AFFECTS,Tumorigenicity,Melanoma
67,m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade.,FTO,AFFECTS,Response  to anti-PD-1 blockade,Melanoma
322,The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging.,FTO,AFFECTS,FOS,granulosa cells
322,The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging.,FOS,INHIBITS,Ovarian Aging,granulosa cells
317,Conditional deficiency of m6A methyltransferase Mettl14 in substantia nigra alters dopaminergic neuron function.,dummy,INHIBITS,Mettl14,Substantia nigra
317,Conditional deficiency of m6A methyltransferase Mettl14 in substantia nigra alters dopaminergic neuron function.,Mettl14,AFFECTS,Dopaminergic neuron function,Substantia nigra
324,EBV downregulates the m6A writer WTAP in EBV-associated gastric carcinoma.,EBV,INHIBITS,WTAP,EBV-associated gastric carcinoma
96,The human methyltransferase ZCCHC4 catalyses N6-methyladenosine modification of 28S ribosomal RNA.,ZCCHC4,AUGMENTS,N6-methyladenosine,Null
96,The human methyltransferase ZCCHC4 catalyses N6-methyladenosine modification of 28S ribosomal RNA.,N6-methyladenosine,LOCATES,28S ribosomal RNA,Null
91,ALKBH5-m6A-FOXM1 signaling axis promotes proliferation and invasion of lung adenocarcinoma cells under intermittent hypoxia.,ALKBH5-m6A-FOXM1 signaling axis,STIMULATES,Proliferation,lung adenocarcinoma cells under intermittent hypoxia
91,ALKBH5-m6A-FOXM1 signaling axis promotes proliferation and invasion of lung adenocarcinoma cells under intermittent hypoxia.,ALKBH5-m6A-FOXM1 signaling axis,STIMULATES,Invasion,lung adenocarcinoma cells under intermittent hypoxia
138,m6A demethylase ALKBH5 promotes proliferation of esophageal squamous cell carcinoma associated with poor prognosis.,ALKBH5,STIMULATES,Proliferation,Esophageal Squamous Cell Carcinoma associated with poor prognosis
138,m6A demethylase ALKBH5 promotes proliferation of esophageal squamous cell carcinoma associated with poor prognosis.,proliferation,ASSOCIATED_WITH,poor prognosis,Esophageal Squamous Cell Carcinoma associated with poor prognosis
178,The RNA m6A reader YTHDF2 maintains oncogene expression and is a targetable dependency in glioblastoma stem cells.,YTHDF2,MAINTAINS,Oncogene expression,Glioblastoma stem cells
249,METTL3 regulates skeletal muscle specific miRNAs at both transcriptional and post-transcriptional levels.,METTL3,AFFECTS,miRNAs,skeletal muscle
72,The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112.,TRMT112,MAINTAINS,METTL5,Null
193,YTHDF1-enhanced iron metabolism depends on TFRC m6A methylation.,YTHDF1,AUGMENTS,Iron metabolism,Null
193,YTHDF1-enhanced iron metabolism depends on TFRC m6A methylation.,Iron metabolism,INTERACTS_WITH,TFRC m6A methylation,Null
189,Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts.,METTL3,INHIBITS,Cardiac Fibrosis,Myocardial Infarction
189,Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts.,myocardial infarction,CAUSES,Cardiac Fibrosis,Myocardial Infarction
189,Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts.,METTL3,INHIBITS,Cardiac Fibroblasts,Myocardial Infarction
189,Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts.,Cardiac Fibroblasts,AFFECTS,Cardiac Fibrosis,Myocardial Infarction
25,Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.,miR-493-3p,INHIBITS,YTHDF2,Prostate Cancer
25,Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.,YTHDF2,INTERACTS_WITH,N6-methyladenosine,Prostate Cancer
25,Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.,YTHDF2,INHIBITS,Prostate Cancer,Prostate Cancer
25,Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.,YTHDF2,STIMULATES,N6-methyladenosine,Prostate Cancer
25,Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels.,N6-methyladenosine,INHIBITS,Prostate Cancer,Prostate Cancer
308,Loss of WTAP Impairs Early Parthenogenetic Embryo Development.,dummy,INHIBITS,WTAP,Early Parthenogenetic Embryo
308,Loss of WTAP Impairs Early Parthenogenetic Embryo Development.,WTAP,INHIBITS,Development,Early Parthenogenetic Embryo
211,Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 upregulation.,Omeprazole,STIMULATES,Chemosensitivity,Gastric Cancer cells
211,Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 upregulation.,Omeprazole,AFFECTS,FTO,Gastric Cancer cells
211,Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 upregulation.,FTO,STIMULATES,mTORC1,Gastric Cancer cells
211,Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 upregulation.,FTO,STIMULATES,DDIT3,Gastric Cancer cells
211,Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 upregulation.,mTORC1,STIMULATES,chemosensitivity,Gastric Cancer cells
211,Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 upregulation.,DDIT3,STIMULATES,chemosensitivity,Gastric Cancer cells
175,m6A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy.,METTL3,AFFECTS,immune responses to anti-PD-1 therapy,Null
175,m6A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy.,METTL14,AFFECTS,immune responses to anti-PD-1 therapy,Null
173,"YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells.",miR-145,INHIBITS,YTHDF2,Ovarian Cancer cells
173,"YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells.",YTHDF2,AFFECTS,Proliferation,Ovarian Cancer cells
173,"YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells.",YTHDF2,AFFECTS,Apoptosis,Ovarian Cancer cells
173,"YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells.",YTHDF2,AFFECTS,Migration,Ovarian Cancer cells
231,Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner.,FTO,PRODUCES,Gefitinib Resistance,Recipient Cells
231,Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner.,FTO,AFFECTS,m6A,Recipient Cells
231,Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner.,m6A,AFFECTS,ABCC10,Recipient Cells
231,Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner.,ABCC10,PRODUCES,Gefitinib Resistance,Recipient Cells
164,Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer.,dummy,STIMULATES,METTL14,Pancreatic Cancer
164,Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer.,METTL14,STIMULATES,PERP mRNA N6 adenosine methylation,Pancreatic Cancer
164,Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer.,PERP mRNA N6 adenosine methylation,STIMULATES,Growth,Pancreatic Cancer
164,Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer.,elevation of PERP mRNA N6 adenosine methylation,STIMULATES,metastasis,Pancreatic Cancer
361,"LINC01605, regulated by the EP300-SMYD2 complex, potentiates the binding between METTL3 and SPTBN2 in colorectal cancer.",EP300-SMYD2 complex,AFFECTS,LINC01605,Colorectal Cancer
361,"LINC01605, regulated by the EP300-SMYD2 complex, potentiates the binding between METTL3 and SPTBN2 in colorectal cancer.",LINC01605,INTERACTS_WITH,METTL3,Colorectal Cancer
361,"LINC01605, regulated by the EP300-SMYD2 complex, potentiates the binding between METTL3 and SPTBN2 in colorectal cancer.",LINC01605,INTERACTS_WITH,SPTBN2,Colorectal Cancer
180,HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification.,HBXIP,STIMULATES,Gastric Cancer,Gastric Cancer
180,HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification.,HBXIP,AFFECTS,METTL3,Gastric Cancer
180,HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification.,METTL3,AFFECTS,MYC mRNA m6A modification,Gastric Cancer
180,HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification.,MYC mRNA m6A modification,STIMULATES,Gastric Cancer,Gastric Cancer
167,METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.,METTL3,AFFECTS,m6A,Endometrioid Epithelial Ovarian Cancer
18,Ubiquitination Regulates the Proteasomal Degradation and Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein.,Ubiquitination,AFFECTS,Proteasomal Degradation,Null
18,Ubiquitination Regulates the Proteasomal Degradation and Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein.,Ubiquitination,AFFECTS,Nuclear Translocation,Null
18,Ubiquitination Regulates the Proteasomal Degradation and Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein.,Proteasomal Degradation,AFFECTS,FTO Protein,Null
18,Ubiquitination Regulates the Proteasomal Degradation and Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein.,Nuclear Translocation,AFFECTS,Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein,Null
194,Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m6A Methylation.,USP5,MAINTAINS,ERK-Phosphorylated METTL3,Null
194,Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m6A Methylation.,ERK-Phosphorylated METTL3,AUGMENTS,m6A Methylation,Null
92,METTL14-Dependent m6A Regulates Vascular Calcification Induced by Indoxyl Sulfate.,METTL14,AFFECTS,m6A,Null
92,METTL14-Dependent m6A Regulates Vascular Calcification Induced by Indoxyl Sulfate.,m6A,AFFECTS,Vascular Calcification,Null
92,METTL14-Dependent m6A Regulates Vascular Calcification Induced by Indoxyl Sulfate.,Indoxyl Sulfate,CAUSES,Vascular Calcification,Null
109,HIV protease cleaves the antiviral m6A reader protein YTHDF3 in the viral particle.,HIV protease,DISRUPTS,YTHDF3,Viral particle
130,Modification of Adenosine by Mettl3 Methyltransferase in the 5'-External Transcribed Spacer of 47S Pre-rRNA Affects rRNA Maturation.,Mettl3,AFFECTS,Adenosine,5'-External Transcribed Spacer of 47S Pre-rRNA
130,Modification of Adenosine by Mettl3 Methyltransferase in the 5'-External Transcribed Spacer of 47S Pre-rRNA Affects rRNA Maturation.,Adenosine,AFFECTS,rRNA Maturation,5'-External Transcribed Spacer of 47S Pre-rRNA
282,WNT/beta-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis.,WNT/beta-catenin,INHIBITS,FTO,Tumor cell glycolysis and tumorigenesis
282,WNT/beta-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis.,FTO,AUGMENTS,m6A,Tumor cell glycolysis and tumorigenesis
282,WNT/beta-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis.,m6A,LOCATES,c-Myc mRNA,Tumor cell glycolysis and tumorigenesis
282,WNT/beta-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis.,c-Myc mRNA,STIMULATES,glycolysis,Tumor cell glycolysis and tumorigenesis
282,WNT/beta-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis.,c-Myc mRNA,STIMULATES,tumorigenesis,Tumor cell glycolysis and tumorigenesis
79,WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.,WTAP,STIMULATES,Progression,Hepatocellular Carcinoma
79,WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.,WTAP,AFFECTS,m6A,Hepatocellular Carcinoma
79,WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.,HuR,INTERACTS_WITH,m6A,Hepatocellular Carcinoma
79,WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.,HuR,INHIBITS,ETS1,Hepatocellular Carcinoma
79,WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.,ETS1,INHIBITS,Progression,Hepatocellular Carcinoma
268,"CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression.",m6A,STIMULATES,CircMETTL3,Breast Cancer
268,"CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression.",CircMETTL3,STIMULATES,Progression,Breast Cancer
261,WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m6A modification of ATF4 mRNA.,WTAP,STIMULATES,Myocardial Ischemia/Reperfusion Injury,myocardial ischemia/reperfusion injury
261,WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m6A modification of ATF4 mRNA.,WTAP,AFFECTS,m6A,myocardial ischemia/reperfusion injury
261,WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m6A modification of ATF4 mRNA.,m6A,LOCATES,ATF4 mRNA,myocardial ischemia/reperfusion injury
261,WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m6A modification of ATF4 mRNA.,ATF4 mRNA,AUGMENTS,Endoplasmic Reticulum Stress,myocardial ischemia/reperfusion injury
261,WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m6A modification of ATF4 mRNA.,Endoplasmic Reticulum Stress,STIMULATES,Myocardial Ischemia/Reperfusion Injury,myocardial ischemia/reperfusion injury
124,"m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.",METTL3,AFFECTS,m6A,Osteosarcoma
124,"m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.",ELAVL1,AFFECTS,m6A,Osteosarcoma
124,"m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.",m6A,STIMULATES,DRG1,Osteosarcoma
124,"m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.",DRG1,STIMULATES,Growth,Osteosarcoma
124,"m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.",DRG1,STIMULATES,Migration,Osteosarcoma
124,"m6A-dependent upregulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.",DRG1,STIMULATES,Colony Formation,Osteosarcoma
279,N6-methyladenosine demethylase FTO impairs hepatic ischemia-reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation.,FTO,INHIBITS,Hepatic Ischemia-Reperfusion Injury,Hepatic Ischemia-Reperfusion Injury
279,N6-methyladenosine demethylase FTO impairs hepatic ischemia-reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation.,FTO,INHIBITS,Drp1,Hepatic Ischemia-Reperfusion Injury
279,N6-methyladenosine demethylase FTO impairs hepatic ischemia-reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation.,Drp1,AFFECTS,Mitochondrial Fragmentation,Hepatic Ischemia-Reperfusion Injury
279,N6-methyladenosine demethylase FTO impairs hepatic ischemia-reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation.,Mitochondrial Fragmentation,INHIBITS,Hepatic Ischemia-Reperfusion Injury,Hepatic Ischemia-Reperfusion Injury
292,The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.,METTL3,STIMULATES,Stemness,Breast Cancer
292,The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.,METTL3,STIMULATES,Malignant Progression,Breast Cancer
292,The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.,METTL3,AFFECTS,m6A,Breast Cancer
292,The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.,m6A,LOCATES,SOX2,Breast Cancer
292,The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.,SOX2,STIMULATES,Stemness,Breast Cancer
292,The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.,SOX2,STIMULATES,Malignant Progression,Breast Cancer
305,METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.,METTL3,STIMULATES,Obstructive Renal Fibrosis,Obstructive Renal Fibrosis
305,METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.,N6-methyladenosine,STIMULATES,Obstructive Renal Fibrosis,Obstructive Renal Fibrosis
305,METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.,miR-21-5p,STIMULATES,Obstructive Renal Fibrosis,Obstructive Renal Fibrosis
305,METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.,METTL3,STIMULATES,SPRY1/ERK/NF-kappaB pathway activation,Obstructive Renal Fibrosis
305,METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.,N6-methyladenosine,STIMULATES,SPRY1/ERK/NF-kappaB pathway activation,Obstructive Renal Fibrosis
305,METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.,miR-21-5p,STIMULATES,SPRY1/ERK/NF-kappaB pathway activation,Obstructive Renal Fibrosis
305,METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.,SPRY1/ERK/NF-kappaB pathway,AFFECTS,inflammation,Obstructive Renal Fibrosis
305,METTL3/N6-methyladenosine/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-kappaB pathway activation.,inflammation,STIMULATES,Obstructive Renal Fibrosis,Obstructive Renal Fibrosis
73,The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA.,METTL3,STIMULATES,M1 macrophage polarization,Null
73,The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA.,METTL3,CONVERTS_TO,STAT1,Null
73,The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA.,STAT1,STIMULATES,M1 macrophage polarization,Null
337,Long noncoding RNA SNHG4 remits lipopolysaccharide-engendered inflammatory lung damage by inhibiting METTL3 - Mediated m6A level of STAT2 mRNA.,SNHG4,INHIBITS,lipopolysaccharide-engendered inflammatory lung damage,Lung
337,Long noncoding RNA SNHG4 remits lipopolysaccharide-engendered inflammatory lung damage by inhibiting METTL3 - Mediated m6A level of STAT2 mRNA.,SNHG4,INHIBITS,METTL3,Lung
337,Long noncoding RNA SNHG4 remits lipopolysaccharide-engendered inflammatory lung damage by inhibiting METTL3 - Mediated m6A level of STAT2 mRNA.,METTL3,AFFECTS,m6A,Lung
337,Long noncoding RNA SNHG4 remits lipopolysaccharide-engendered inflammatory lung damage by inhibiting METTL3 - Mediated m6A level of STAT2 mRNA.,m6A,LOCATES,STAT2,Lung
337,Long noncoding RNA SNHG4 remits lipopolysaccharide-engendered inflammatory lung damage by inhibiting METTL3 - Mediated m6A level of STAT2 mRNA.,STAT2,INHIBITS,lipopolysaccharide-engendered inflammatory lung damage,Lung
291,Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin.,FTO,AFFECTS,STAT3,Breast Cancer
291,Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin.,STAT3,INHIBITS,doxorubicin,Breast Cancer
366,METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.,METTL3,STIMULATES,miR-222-3p,Thyroid Carcinoma
366,METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.,miR-222-3p,INHIBITS,STK4,Thyroid Carcinoma
366,METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.,miR-222-3p,STIMULATES,Malignant Behaviors,Thyroid Carcinoma
118,Progression of Thyroid Carcinoma Is Promoted by the m6A Methyltransferase METTL3 Through Regulating m6A Methylation on TCF1.,METTL3,STIMULATES,Progression,Thyroid Carcinoma
118,Progression of Thyroid Carcinoma Is Promoted by the m6A Methyltransferase METTL3 Through Regulating m6A Methylation on TCF1.,METTL3,AFFECTS,m6A,Thyroid Carcinoma
118,Progression of Thyroid Carcinoma Is Promoted by the m6A Methyltransferase METTL3 Through Regulating m6A Methylation on TCF1.,m6A,LOCATES,TCF1,Thyroid Carcinoma
118,Progression of Thyroid Carcinoma Is Promoted by the m6A Methyltransferase METTL3 Through Regulating m6A Methylation on TCF1.,TCF1,STIMULATES,Progression,Thyroid Carcinoma
166,METTL3 potentiates resistance to cisplatin through m6A modification of TFAP2C in seminoma.,METTL3,AFFECTS,m6A,Seminoma
166,METTL3 potentiates resistance to cisplatin through m6A modification of TFAP2C in seminoma.,m6A,LOCATES,TFAP2C,Seminoma
166,METTL3 potentiates resistance to cisplatin through m6A modification of TFAP2C in seminoma.,TFAP2C,PREVENTS,cisplatin,Seminoma
166,METTL3 potentiates resistance to cisplatin through m6A modification of TFAP2C in seminoma.,METTL3,PREVENTS,cisplatin,Seminoma
230,Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer.,Tumor-Associated Macrophages,STIMULATES,Oxaliplatin Resistance,Colorectal Cancer
230,Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer.,Tumor-Associated Macrophages,AFFECTS,METTL3,Colorectal Cancer
230,Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer.,METTL3,AFFECTS,m6A,Colorectal Cancer
230,Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer.,m6A,LOCATES,TRAF5,Colorectal Cancer
230,Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer.,TRAF5,STIMULATES,Oxaliplatin Resistance,Colorectal Cancer
230,Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer.,Tumor-Associated Macrophages,AFFECTS,Necroptosis,Colorectal Cancer
230,Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m6A of TRAF5 and Necroptosis in Colorectal Cancer.,Necroptosis,STIMULATES,Oxaliplatin Resistance,Colorectal Cancer
285,The N6-methyladenosine RNA-binding protein YTHDF1 modulates the translation of TRAF6 to mediate the intestinal immune response.,YTHDF1,AFFECTS,TRAF6,Null
285,The N6-methyladenosine RNA-binding protein YTHDF1 modulates the translation of TRAF6 to mediate the intestinal immune response.,TRAF6,AFFECTS,Intestinal immune response,Null
187,YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.,YTHDF2,AFFECTS,tumor suppressors,Prostate Cancer
187,YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.,tumor suppressors,CAUSES,AKT phosphorylation,Prostate Cancer
187,YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.,YTHDF2,AFFECTS,N6-methyladenosine,Prostate Cancer
187,YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.,N6-methyladenosine,AFFECTS,AKT phosphorylation,Prostate Cancer
56,The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.,FTO,STIMULATES,Lung Cancer Cells,Lung Cancer
56,The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.,FTO,AFFECTS,m6A,Lung Cancer
56,The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.,m6A,LOCATES,USP7,Lung Cancer
56,The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.,USP7,STIMULATES,Lung Cancer Cells,Lung Cancer
288,Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A.,dummy,INHIBITS,ALKBH5,Null
288,Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A.,ALKBH5,STIMULATES,angiogenesis,Null
288,Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A.,ALKBH5,MAINTAINS,WNT5A,Null
288,Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A.,WNT5A,STIMULATES,angiogenesis,Null
330,N6-methyladenosine-mediated upregulation of WTAPP1 promotes WTAP translation and Wnt signaling to facilitate pancreatic cancer progression.,N6-methyladenosine,STIMULATES,WTAPP1,Pancreatic Cancer
330,N6-methyladenosine-mediated upregulation of WTAPP1 promotes WTAP translation and Wnt signaling to facilitate pancreatic cancer progression.,WTAPP1,STIMULATES,WTAP,Pancreatic Cancer
330,N6-methyladenosine-mediated upregulation of WTAPP1 promotes WTAP translation and Wnt signaling to facilitate pancreatic cancer progression.,WTAPP1,STIMULATES,Wnt,Pancreatic Cancer
330,N6-methyladenosine-mediated upregulation of WTAPP1 promotes WTAP translation and Wnt signaling to facilitate pancreatic cancer progression.,WTAP,STIMULATES,Progression,Pancreatic Cancer
330,N6-methyladenosine-mediated upregulation of WTAPP1 promotes WTAP translation and Wnt signaling to facilitate pancreatic cancer progression.,Wnt,STIMULATES,Progression,Pancreatic Cancer
201,Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1.,Musashi-1,STIMULATES,YTHDF1,Glioblastoma
201,Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1.,YTHDF1,STIMULATES,Cancer stem cell properties,Glioblastoma
201,Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1.,Musashi-1,STIMULATES,Cancer stem cell properties,Glioblastoma
43,m6A facilitates hippocampus-dependent learning and memory through YTHDF1.,m6A,STIMULATES,hippocampus,Null
43,m6A facilitates hippocampus-dependent learning and memory through YTHDF1.,m6A,AFFECTS,YTHDF1,Null
43,m6A facilitates hippocampus-dependent learning and memory through YTHDF1.,YTHDF1,STIMULATES,hippocampus,Null
51,m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner.,m6A methylation,AFFECTS,Pluripotency,porcine induced Pluripotent Stem Cells
51,m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner.,m6A methylation,AFFECTS,YTHDF1,porcine induced Pluripotent Stem Cells
51,m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner.,m6A methylation,AFFECTS,YTHDF2,porcine induced Pluripotent Stem Cells
51,m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner.,YTHDF1,INTERACTS_WITH,SOCS3/JAK2/STAT3 pathway,porcine induced Pluripotent Stem Cells
51,m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner.,YTHDF2,INTERACTS_WITH,SOCS3/JAK2/STAT3 pathway,porcine induced Pluripotent Stem Cells
51,m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner.,SOCS3/JAK2/STAT3 pathway,AFFECTS,Pluripotency,porcine induced Pluripotent Stem Cells
248,Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma.,Histone lactylation,STIMULATES,Oncogenesis,Ocular Melanoma
248,Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma.,Histone lactylation,STIMULATES,YTHDF2,Ocular Melanoma
248,Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma.,YTHDF2,STIMULATES,Oncogenesis,Ocular Melanoma
262,KDM5B promotes self-renewal of hepatocellular carcinoma cells through the microRNA-448-mediated YTHDF3/ITGA6 axis.,KDM5B,STIMULATES,hepatocellular carcinoma cells,Hepatocellular Carcinoma
262,KDM5B promotes self-renewal of hepatocellular carcinoma cells through the microRNA-448-mediated YTHDF3/ITGA6 axis.,KDM5B,AFFECTS,microRNA-448,Hepatocellular Carcinoma
262,KDM5B promotes self-renewal of hepatocellular carcinoma cells through the microRNA-448-mediated YTHDF3/ITGA6 axis.,microRNA-448,AFFECTS,YTHDF3/ITGA6 axis,Hepatocellular Carcinoma
262,KDM5B promotes self-renewal of hepatocellular carcinoma cells through the microRNA-448-mediated YTHDF3/ITGA6 axis.,YTHDF3/ITGA6 axis,STIMULATES,hepatocellular carcinoma cells,Hepatocellular Carcinoma
232,SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.,dummy,STIMULATES,YTHDF2,Cancer Progression
232,SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.,YTHDF2,STIMULATES,mRNA degradation,Cancer Progression
232,SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.,YTHDF2,STIMULATES,Cancer Progression,Cancer Progression
232,SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.,YTHDF2,INTERACTS_WITH,m6A-modified mRNAs,Cancer Progression
232,SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.,m6A-modified mRNAs,STIMULATES,mRNA degradation,Cancer Progression
232,SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.,m6A-modified mRNAs,STIMULATES,Cancer Progression,Cancer Progression
147,METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.,METTL3,STIMULATES,Homologous Recombination,DBS
147,METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.,N6-Methyladenosine,STIMULATES,Homologous Recombination,DBS
147,METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.,Homologous Recombination,AFFECTS,Repair,DBS
147,METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.,METTL3,AFFECTS,DNA-RNA Hybrid Accumulation,DBS
147,METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.,N6-Methyladenosine,AFFECTS,DNA-RNA Hybrid Accumulation,DBS
147,METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.,DNA-RNA Hybrid Accumulation,AFFECTS,Repair,DBS
19,R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling.,R-2HG,INTERACTS_WITH,FTO/m6A/MYC/CEBPA Signaling,Null
19,R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling.,FTO/m6A/MYC/CEBPA Signaling,MANIFESTS,Anti-tumor Activity,Null
19,R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling.,R-2HG,MANIFESTS,Anti-tumor Activity,Null
219,R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis.,R-2-hydroxyglutarate,INHIBITS,aerobic glycolysis,Leukemia
219,R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis.,R-2-hydroxyglutarate,INTERACTS_WITH,FTO/m6A/PFKP/LDHB axis,Leukemia
219,R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis.,FTO/m6A/PFKP/LDHB axis,INHIBITS,aerobic glycolysis,Leukemia
165,m6A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling Axis.,YTHDC2,STIMULATES,Radiotherapy Resistance,Nasopharyngeal Carcinoma
165,m6A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling Axis.,YTHDC2,STIMULATES,IGF1R/AKT/S6 Signaling Axis,Nasopharyngeal Carcinoma
165,m6A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling Axis.,IGF1R/AKT/S6 Signaling Axis,STIMULATES,Radiotherapy Resistance,Nasopharyngeal Carcinoma
63,METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.,METTL3,STIMULATES,experimental osteoarthritis development,Experimental Osteoarthritis
63,METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.,METTL3,AFFECTS,Inflammatory Response,Experimental Osteoarthritis
63,METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.,METTL3,AFFECTS,Apoptosis,Experimental Osteoarthritis
63,METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.,Apoptosis,LOCATES,Chondrocyte,Experimental Osteoarthritis
63,METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.,Inflammatory Response,STIMULATES,experimental osteoarthritis development,Experimental Osteoarthritis
63,METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte.,Apoptosis,STIMULATES,experimental osteoarthritis development,Experimental Osteoarthritis
62,METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.,METTL3,AFFECTS,Keap1/Nrf2 Pathway,Colistin-Induced Kidney Injury
62,METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.,m6A,AFFECTS,Keap1/Nrf2 Pathway,Colistin-Induced Kidney Injury
62,METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.,miRNA-873-5p,AFFECTS,Keap1/Nrf2 Pathway,Colistin-Induced Kidney Injury
62,METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.,Keap1/Nrf2 Pathway,INHIBITS,Oxidative Stress,Colistin-Induced Kidney Injury
62,METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.,Keap1/Nrf2 Pathway,INHIBITS,Apoptosis,Colistin-Induced Kidney Injury
62,METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.,METTL3,INHIBITS,Oxidative Stress,Colistin-Induced Kidney Injury
62,METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.,m6A,INHIBITS,Oxidative Stress,Colistin-Induced Kidney Injury
62,METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.,miRNA-873-5p,INHIBITS,Oxidative Stress,Colistin-Induced Kidney Injury
62,METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.,METTL3,INHIBITS,Apoptosis,Colistin-Induced Kidney Injury
62,METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.,m6A,INHIBITS,Apoptosis,Colistin-Induced Kidney Injury
62,METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway.,miRNA-873-5p,INHIBITS,Apoptosis,Colistin-Induced Kidney Injury
269,Circular RNA hsa_circ_0072309 promotes tumorigenesis and invasion by regulating the miR-607/FTO axis in non-small cell lung carcinoma.,hsa_circ_0072309,STIMULATES,Tumorigenesis,Non-small cell lung carcinoma
269,Circular RNA hsa_circ_0072309 promotes tumorigenesis and invasion by regulating the miR-607/FTO axis in non-small cell lung carcinoma.,hsa_circ_0072309,STIMULATES,Invasion,Non-small cell lung carcinoma
269,Circular RNA hsa_circ_0072309 promotes tumorigenesis and invasion by regulating the miR-607/FTO axis in non-small cell lung carcinoma.,hsa_circ_0072309,AFFECTS,miR-607/FTO axis,Non-small cell lung carcinoma
269,Circular RNA hsa_circ_0072309 promotes tumorigenesis and invasion by regulating the miR-607/FTO axis in non-small cell lung carcinoma.,miR-607/FTO axis,STIMULATES,Tumorigenesis,Non-small cell lung carcinoma
269,Circular RNA hsa_circ_0072309 promotes tumorigenesis and invasion by regulating the miR-607/FTO axis in non-small cell lung carcinoma.,miR-607/FTO axis,STIMULATES,Invasion,Non-small cell lung carcinoma
7,FTO is required for myogenesis by positively regulating mTOR-PGC-1alpha pathway-mediated mitochondria biogenesis.,FTO,CAUSES,myogenesis,Null
7,FTO is required for myogenesis by positively regulating mTOR-PGC-1alpha pathway-mediated mitochondria biogenesis.,FTO,STIMULATES,mTOR-PGC-1alpha pathway,Null
7,FTO is required for myogenesis by positively regulating mTOR-PGC-1alpha pathway-mediated mitochondria biogenesis.,mTOR-PGC-1alpha pathway,AFFECTS,mitochondria biogenesis,Null
7,FTO is required for myogenesis by positively regulating mTOR-PGC-1alpha pathway-mediated mitochondria biogenesis.,mitochondria biogenesis,CAUSES,myogenesis,Null
21,METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification.,METTL14,AFFECTS,m6A,Hematopoietic Stem/Progenitor
21,METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification.,m6A,INHIBITS,Differentiation,Hematopoietic Stem/Progenitor
21,METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification.,m6A,STIMULATES,Leukemogenesis,Hematopoietic Stem/Progenitor
21,METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification.,METTL14,INHIBITS,Differentiation,Hematopoietic Stem/Progenitor
21,METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification.,METTL14,STIMULATES,Leukemogenesis,Hematopoietic Stem/Progenitor
312,YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decay.,YTHDF2,INHIBITS,Cardiac Hypertrophy,Cardiac Hypertrophy
312,YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decay.,YTHDF2,AFFECTS,Myh7,Cardiac Hypertrophy
312,YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decay.,Myh7,INHIBITS,Cardiac Hypertrophy,Cardiac Hypertrophy
128,RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-kappaB pathway.,ALKBH5,STIMULATES,Ovarian Carcinogenesis,simulated tumour microenvironment
128,RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-kappaB pathway.,ALKBH5,STIMULATES,NF-kappaB Pathway,simulated tumour microenvironment
128,RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-kappaB pathway.,NF-kappaB Pathway,STIMULATES,Ovarian Carcinogenesis,simulated tumour microenvironment
354,METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway.,METTL3,AFFECTS,m6A,Esophageal Cancer
354,METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway.,m6A,AFFECTS,Notch signaling pathway,Esophageal Cancer
354,METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway.,Notch signaling pathway,STIMULATES,initiation,Esophageal Cancer
354,METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway.,Notch signaling pathway,STIMULATES,progression,Esophageal Cancer
354,METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway.,m6A,STIMULATES,initiation,Esophageal Cancer
354,METTL3-mediated m6A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway.,m6A,STIMULATES,progression,Esophageal Cancer
121,High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration.,WTAP,CAUSES,prognosis,Gastric Cancer
121,High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration.,WTAP,AFFECTS,T lymphocyte infiltration,Gastric Cancer
121,High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration.,T lymphocyte infiltration,CAUSES,prognosis,Gastric Cancer
335,METTL3-induced UCK2 m6A hypermethylation promotes melanoma cancer cell metastasis via the WNT/beta-catenin pathway.,METTL3,CAUSES,UCK2,Melanoma Cancer
335,METTL3-induced UCK2 m6A hypermethylation promotes melanoma cancer cell metastasis via the WNT/beta-catenin pathway.,UCK2,AFFECTS,WNT/beta-catenin pathway,Melanoma Cancer
335,METTL3-induced UCK2 m6A hypermethylation promotes melanoma cancer cell metastasis via the WNT/beta-catenin pathway.,WNT/beta-catenin pathway,STIMULATES,Metastasis,Melanoma Cancer
11,Mettl3-mediated m6A regulates spermatogonial differentiation and meiosis initiation.,Mettl3,AFFECTS,m6A,Null
11,Mettl3-mediated m6A regulates spermatogonial differentiation and meiosis initiation.,m6A,AFFECTS,spermatogonial differentiation,Null
11,Mettl3-mediated m6A regulates spermatogonial differentiation and meiosis initiation.,m6A,AFFECTS,meiosis initiation,Null
13,The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.,METTL3,AFFECTS,Myeloid differentiation,normal hematopoietic and leukemia cell
23,The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells.,METTL3,STIMULATES,chemo-resistance,Pancreatic Cancer Cells
23,The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells.,METTL3,STIMULATES,radioresistance,Pancreatic Cancer Cells
33,METTL3-mediated m6A modification is required for cerebellar development.,METTL3,AFFECTS,m6A,Cerebellar Development
33,METTL3-mediated m6A modification is required for cerebellar development.,m6A,CAUSES,cerebellar development,Cerebellar Development
42,N6-methyladenosine modification and METTL3 modulate enterovirus 71 replication.,N6-methyladenosine,AFFECTS,Replication,Enterovirus 71
42,N6-methyladenosine modification and METTL3 modulate enterovirus 71 replication.,METTL3,AFFECTS,Replication,Enterovirus 71
44,Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis.,Mettl3,AFFECTS,m6A RNA methylation,Osteoporosis
44,Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis.,m6A RNA methylation,AFFECTS,bone marrow mesenchymal stem cells,Osteoporosis
44,Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis.,m6A RNA methylation,AFFECTS,Osteoporosis,Osteoporosis
58,Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation.,METTL3,AFFECTS,m6A methylation,dendritic cell
58,Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation.,m6A methylation,STIMULATES,dendritic cell,dendritic cell
85,METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.,METTL3,AFFECTS,N6-methyladenosine,Gastric Cancer
85,METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.,N6-methyladenosine modification,CAUSES,epithelial-mesenchymal transition,Gastric Cancer
85,METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.,N6-methyladenosine modification,CAUSES,metastasis,Gastric Cancer
259,m6A-independent genome-wide METTL3 and METTL14 redistribution drives the senescence-associated secretory phenotype.,METTL3,STIMULATES,the senescence-associated secretory phenotype,Null
259,m6A-independent genome-wide METTL3 and METTL14 redistribution drives the senescence-associated secretory phenotype.,METTL14,STIMULATES,the senescence-associated secretory phenotype,Null
266,A methionine-Mettl3-N6-methyladenosine axis promotes polycystic kidney disease.,methionine-Mettl3-N6-methyladenosine axis,STIMULATES,Polycystic Kidney Disease,Polycystic Kidney Disease
280,METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.,METTL3,AFFECTS,m6A,SARS-CoV-2 infection
280,METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.,METTL3,AFFECTS,host cell innate immune responses,SARS-CoV-2 infection
326,Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.,dummy,INHIBITS,METTL3,Prostate Cancer
326,Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.,METTL3,INHIBITS,Invasion,Prostate Cancer
326,Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.,METTL3,INHIBITS,Metastasis,Prostate Cancer
334,Loss of m6A methyltransferase METTL3 promotes heart regeneration and repair after myocardial injury.,dummy,INHIBITS,METTL3,Myocardial Injury
334,Loss of m6A methyltransferase METTL3 promotes heart regeneration and repair after myocardial injury.,METTL3,STIMULATES,Regeneration,Myocardial Injury
334,Loss of m6A methyltransferase METTL3 promotes heart regeneration and repair after myocardial injury.,METTL3,STIMULATES,repair,Myocardial Injury
347,METTL3-mediated RNA m6A hypermethylation promotes tumorigenesis and GH secretion of pituitary somatotroph adenomas.,METTL3,AFFECTS,m6A hypermethylation,Pituitary somatotroph adenomas
347,METTL3-mediated RNA m6A hypermethylation promotes tumorigenesis and GH secretion of pituitary somatotroph adenomas.,m6A hypermethylation,STIMULATES,Tumorigenesis,Pituitary somatotroph adenomas
347,METTL3-mediated RNA m6A hypermethylation promotes tumorigenesis and GH secretion of pituitary somatotroph adenomas.,m6A hypermethylation,STIMULATES,GH secretion,Pituitary somatotroph adenomas
358,METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors.,METTL3,AFFECTS,MALAT1,Thymic Epithelial Tumors
358,METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors.,MALAT1,STIMULATES,c-Myc,Thymic Epithelial Tumors
359,METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells.,METTL3,AFFECTS,m6A methylation,natural killer cell
359,METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells.,m6A methylation,STIMULATES,Anti-tumour immunity,natural killer cell
363,METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease.,METTL3-m6A-Rubicon axis,INHIBITS,Autophagy,Nonalcoholic fatty liver disease
242,SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice.,SEDT2,AFFECTS,m6A methylation,pulmonary arterial hypertension in mice
242,SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice.,METTL14,AFFECTS,m6A methylation,pulmonary arterial hypertension in mice
242,SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice.,m6A methylation,AFFECTS,pulmonary arterial hypertension,pulmonary arterial hypertension in mice
242,SEDT2/METTL14-mediated m6A methylation awakening contributes to hypoxia-induced pulmonary arterial hypertension in mice.,hypoxia,CAUSES,pulmonary arterial hypertension,pulmonary arterial hypertension in mice
338,METTL14 facilitates global genome repair and suppresses skin tumorigenesis.,METTL14,STIMULATES,Global Genome Repair,Skin Tumorigenesis
338,METTL14 facilitates global genome repair and suppresses skin tumorigenesis.,METTL14,INHIBITS,Skin Tumorigenesis,Skin Tumorigenesis
10,The U6 snRNA m6A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention.,METTL16,AFFECTS,SAM Synthetase Intron Retention,Null
122,The rRNA m6A methyltransferase METTL5 is involved in pluripotency and developmental programs.,METTL5,ASSOCIATED_WITH,pluripotency,Null
122,The rRNA m6A methyltransferase METTL5 is involved in pluripotency and developmental programs.,METTL5,ASSOCIATED_WITH,developmental programs,Null
131,The 18S ribosomal RNA m6A methyltransferase Mettl5 is required for normal walking behavior in Drosophila.,Mettl5,CAUSES,Normal walking behavior,Drosophila
205,Ribosome 18S m6A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth.,METTL5,STIMULATES,Translation Initiation,Breast Cancer
205,Ribosome 18S m6A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth.,METTL5,STIMULATES,Cell Growth,Breast Cancer
141,Loss of the RNA-binding protein Rbm15 disrupts liver maturation in zebrafish.,dummy,INHIBITS,Rbm15,zebrafish
141,Loss of the RNA-binding protein Rbm15 disrupts liver maturation in zebrafish.,Rbm15,DISRUPTS,Liver maturation,zebrafish
9,Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis.,FTO,AFFECTS,Adult neurogenesis,Null
